x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
Delaware
|
|
42-1406317
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification Number)
|
|
|
|
7700 Forsyth Boulevard
|
|
|
St. Louis, Missouri
|
|
63105
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Common Stock, $0.001 Par Value
|
|
New York Stock Exchange
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
Large accelerated filer
x
|
Accelerated filer
|
o
|
Non-accelerated filer
o
(do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
Emerging growth company
|
o
|
|
|
|
PAGE
|
Part I
|
|||
Item 1.
|
|
||
Item 1A.
|
|
||
Item 1B.
|
|
||
Item 2.
|
|
||
Item 3.
|
|
||
Item 4.
|
|
||
Part II
|
|||
Item 5.
|
|
||
Item 6.
|
|
||
Item 7.
|
|
||
Item 7A.
|
|
||
Item 8.
|
|
||
Item 9.
|
|
||
Item 9A.
|
|
||
Item 9B.
|
|
||
Part III
|
|||
Item 10.
|
|
||
Item 11.
|
|
||
Item 12.
|
|
||
Item 13.
|
|
||
Item 14.
|
|
||
Part IV
|
|||
Item 15.
|
|
||
Item 16.
|
|
||
|
|
||
|
|
|
|
|
|
|
|
•
|
our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves;
|
•
|
competition;
|
•
|
membership and revenue declines or unexpected trends;
|
•
|
changes in healthcare practices, new technologies, and advances in medicine;
|
•
|
increased healthcare costs;
|
•
|
changes in economic, political or market conditions;
|
•
|
changes in federal or state laws or regulations, including changes with respect to government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder that may result from changing political conditions;
|
•
|
rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;
|
•
|
our ability to adequately price products on federally facilitated and state based Health Insurance Marketplaces;
|
•
|
tax matters;
|
•
|
disasters or major epidemics;
|
•
|
the outcome of legal and regulatory proceedings;
|
•
|
changes in expected contract start dates;
|
•
|
provider, state, federal and other contract changes and timing of regulatory approval of contracts;
|
•
|
the expiration, suspension, or termination of our or Fidelis Care's contracts with federal or state governments (including but not limited to Medicaid, Medicare, and TRICARE);
|
•
|
the difficulty of predicting the timing or outcome of pending or future litigation or government investigations;
|
•
|
challenges to our or Fidelis Care's contract awards;
|
•
|
cyber-attacks or other privacy or data security incidents;
|
•
|
the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the acquisition (Health Net Acquisition) of Health Net, Inc. (Health Net), and the Proposed Fidelis Acquisition, will not be realized, or will not be realized within the expected time period, including, but not limited to, as a result of any failure to obtain any regulatory, governmental or third party consents or approvals in connection with the Proposed Fidelis Acquisition (including any such approvals under the New York Non-For-Profit Corporation Law) or any conditions, terms, obligations or restrictions imposed in connection with the receipt of such consents or approvals;
|
•
|
the exertion of management’s time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Health Net Acquisition;
|
•
|
disruption caused by significant completed and pending acquisitions, including the Health Net Acquisition and the Proposed Fidelis Acquisition, making it more difficult to maintain business and operational relationships;
|
•
|
the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions, including among others, the Health Net Acquisition and the Proposed Fidelis Acquisition;
|
•
|
changes in expected closing dates, estimated purchase price and accretion for acquisitions;
|
•
|
the risk that acquired businesses, including Health Net and Fidelis Care, will not be integrated successfully;
|
•
|
the risk that the conditions to the completion of the Proposed Fidelis Acquisition may not be satisfied or completed on a timely basis, or at all;
|
•
|
failure to obtain or receive any required regulatory approvals, consents or clearances for the Proposed Fidelis Acquisition, and the risk that, even if so obtained or received, regulatory authorities impose conditions on the completion of the transaction that could require the exertion of management's time and our resources or otherwise have an adverse effect on Centene;
|
•
|
business uncertainties and contractual restrictions while the Proposed Fidelis Acquisition is pending, which could adversely affect our business and operations;
|
•
|
change of control provisions or other provisions in certain agreements to which Fidelis Care is a party, which may be triggered by the completion of the Proposed Fidelis Acquisition;
|
•
|
loss of management personnel and other key employees due to uncertainties associated with the Proposed Fidelis Acquisition;
|
•
|
the risk that, following completion of the Proposed Fidelis Acquisition, the combined company may not be able to effectively manage its expanded operations;
|
•
|
restrictions and limitations that may stem from the financing arrangements that the combined company will enter into in connection with the Proposed Fidelis Acquisition;
|
•
|
our ability to achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;
|
•
|
availability of debt and equity financing, on terms that are favorable to us;
|
•
|
inflation; and
|
•
|
foreign currency fluctuations.
|
|
Year Ended December 31,
|
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
|
||||||
|
|
|
|
|
|
|
||||||
GAAP net earnings from continuing operations
|
$
|
828
|
|
|
$
|
559
|
|
|
$
|
356
|
|
|
Amortization of acquired intangible assets
|
156
|
|
|
147
|
|
|
24
|
|
|
|||
Acquisition related expenses
|
20
|
|
|
234
|
|
|
27
|
|
|
|||
Penn Treaty assessment expense
|
56
|
|
|
—
|
|
|
—
|
|
|
|||
Cost sharing reductions
|
22
|
|
|
—
|
|
|
—
|
|
|
|||
Income Tax Reform
|
(125
|
)
|
|
—
|
|
|
—
|
|
|
|||
Charitable contribution
(1)
|
40
|
|
|
50
|
|
|
—
|
|
|
|||
California minimum medical loss ratio change
|
—
|
|
|
(195
|
)
|
|
—
|
|
|
|||
Debt extinguishment
|
—
|
|
|
11
|
|
|
—
|
|
|
|||
Income tax effects of adjustments
(2)
|
(108
|
)
|
|
(79
|
)
|
|
(20
|
)
|
|
|||
Adjusted net earnings from continuing operations
|
$
|
889
|
|
|
$
|
727
|
|
|
$
|
387
|
|
|
|
|
|
|
|
|
|
||||||
GAAP diluted earnings per share (EPS) from continuing operations
|
$
|
4.69
|
|
|
$
|
3.41
|
|
|
$
|
2.89
|
|
|
Amortization of acquired intangible assets
(3)
|
0.56
|
|
|
0.57
|
|
|
0.11
|
|
|
|||
Acquisition related expenses
(4)
|
0.07
|
|
|
0.98
|
|
|
0.14
|
|
|
|||
Penn Treaty assessment expense
(5)
|
0.20
|
|
|
—
|
|
|
—
|
|
|
|||
Cost sharing reductions
(6)
|
0.08
|
|
|
—
|
|
|
—
|
|
|
|||
Income Tax Reform
|
(0.71
|
)
|
|
—
|
|
|
—
|
|
|
|||
Charitable contribution
(7)
|
0.14
|
|
|
0.19
|
|
|
—
|
|
|
|||
California minimum medical loss ratio change
(8)
|
—
|
|
|
(0.76
|
)
|
|
—
|
|
|
|||
Debt extinguishment
(9)
|
—
|
|
|
0.04
|
|
|
—
|
|
|
|||
Adjusted Diluted EPS from continuing operations
|
$
|
5.03
|
|
|
$
|
4.43
|
|
|
$
|
3.14
|
|
|
(1)
|
In connection with the favorable impact of the Tax Cuts and Jobs Act (Income Tax Reform) passed in late 2017 and the additional revenue associated with the California minimum medical loss ratio (MLR) change in 2016, the Company made charitable commitments to its foundation in 2017 and 2016, respectively.
|
(2)
|
The income tax effects of adjustments are based on the effective income tax rates applicable to adjusted (non-GAAP) results. There is no additional income tax effect from Income Tax Reform.
|
(3)
|
Amortization of acquired intangible assets per diluted share is net of an income tax benefit of
$0.32
,
$0.33
, and
$0.08
for the
years ended December 31, 2017, 2016 and 2015
, respectively.
|
(4)
|
Acquisition related expenses per diluted share are net of an income tax benefit of
$0.04
,
$0.45
and
$0.08
for the
years ended December 31, 2017, 2016 and 2015
, respectively.
|
(5)
|
The Penn Treaty assessment expense per diluted share is net of an income tax benefit of
$0.12
for the year ended December 31, 2017.
|
(6)
|
The cost sharing reduction (CSR) expense per diluted share is net of an income tax benefit of
$0.04
for the year ended December 31, 2017.
|
(7)
|
The charitable contributions per diluted share are net of an income tax benefit of
$0.09
and
$0.11
for the years ended December 31, 2017 and 2016, respectively.
|
(8)
|
The impact associated with the retroactive contract amendment received in the fourth quarter of 2016 that changed the minimum MLR calculation per diluted share is net of the income tax expense of
$(0.43)
for the year ended December 31, 2016.
|
(9)
|
The debt extinguishment cost per diluted share is net of the income tax benefit of
$0.03
for the year ended December 31, 2016.
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
GAAP selling, general and administrative expenses
|
$
|
4,446
|
|
|
$
|
3,676
|
|
|
$
|
1,802
|
|
Acquisition related expenses
|
20
|
|
|
234
|
|
|
27
|
|
|||
Penn Treaty assessment expense
|
56
|
|
|
—
|
|
|
—
|
|
|||
Charitable contribution
|
40
|
|
|
50
|
|
|
—
|
|
|||
Adjusted selling, general and administrative expenses
|
$
|
4,330
|
|
|
$
|
3,392
|
|
|
$
|
1,775
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2017
|
|
2016
|
||||
Net earnings from continuing operations attributable to Centene Corporation
|
|
$
|
828
|
|
|
$
|
559
|
|
Income tax expense
|
|
326
|
|
|
599
|
|
||
Interest expense
|
|
255
|
|
|
217
|
|
||
Depreciation and amortization
|
|
362
|
|
|
281
|
|
||
Non-cash stock compensation expense
|
|
135
|
|
|
148
|
|
||
Adjusted EBITDA
(1)
|
|
$
|
1,906
|
|
|
$
|
1,804
|
|
•
|
Expertise in Government Sponsored Programs.
For more than 30 years, we have developed a specialized government services expertise that has helped us establish and maintain relationships with members, providers and state governments. We have implemented programs developed to achieve savings for state governments and improve medical outcomes for members by reducing inappropriate emergency room use, inpatient days and high cost interventions, as well as by managing care of chronic illnesses. We work with state agencies in order to maximize the effectiveness of their programs. Our approach is to accomplish this while maintaining adequate levels of provider compensation and protecting our profitability.
|
•
|
Strong Historic Operating Performance.
We have increased revenues as we have grown in existing markets, expanded into new markets and broadened our product offerings. We entered the Wisconsin market in 1984 as a single health plan and have grown to serve 29 states. Our operating performance has been demonstrated by the following:
|
|
|
2017
|
|
2016
|
|
% Change
2016 - 2017
|
||||
Total membership (in millions)
|
|
12.2
|
|
|
11.4
|
|
|
7%
|
||
Total revenues ($ in billions)
|
|
$
|
48.4
|
|
|
$
|
40.6
|
|
|
19%
|
Net earnings from continuing operations attributable to Centene Corporation ($ in millions)
|
|
$
|
828
|
|
|
$
|
559
|
|
|
48%
|
Diluted earnings per share (EPS)
|
|
$
|
4.69
|
|
|
$
|
3.41
|
|
|
38%
|
Adjusted Diluted EPS
|
|
$
|
5.03
|
|
|
$
|
4.43
|
|
|
14%
|
Adjusted EBITDA
|
|
$
|
1,906
|
|
|
$
|
1,804
|
|
|
6%
|
•
|
Financial Strength and Scale.
Our size and scale allow us to grow, diversify and invest in our businesses through strategic acquisitions and investments in technology and other resources that support our business and help us navigate the changing healthcare landscape.
|
•
|
Innovative Technology and Scalable Systems.
The ability to access data and translate it into meaningful information is essential to operating across a multi-state service area in a cost-effective manner. Our centralized information systems support our core processing functions under a set of integrated databases and are designed to be both replicable and scalable to accommodate organic growth and growth from acquisitions. We continue to enhance our systems in order to leverage the platform we have developed for our existing states for configuration into new states or health plan acquisitions. We believe our predictive modeling technology enables our medical management operations to proactively case and disease manage specific high risk members. It can recommend medical care opportunities using a mix of company defined algorithms and evidence based medical guidelines. Interventions are determined by the clinical indicators, the ability to improve health outcomes, and the risk profile of members. We believe our integrated approach helps to assure that consistent sources of claim and member information are provided across all of our health plans. Our membership and claims processing system is capable of expanding to support additional members in an efficient manner.
|
•
|
Diversified Business Lines.
We continue to broaden our service offerings to address areas that we believe have been traditionally under-served by Medicaid managed care organizations. In addition to our Medicaid and Medicaid-related managed care services, our service offerings include behavioral health management, care management software, correctional healthcare services, dental benefits management, commercial programs, home-based primary care services, life and health management, vision benefits management, pharmacy benefits management, specialty pharmacy and telehealth services. With the acquisition of Health Net, we further broadened our service offerings in 2016, which added government-sponsored care under its federal contracts with the Department of Defense (DoD) and the U.S. Department of Veterans Affairs (VA), as well as Medicare Advantage. Through the utilization of a multi-business line approach, we are able to improve the quality of care, improve outcomes, diversify our revenues and help control our medical costs.
|
•
|
Localized Approach with Centralized Support Infrastructure.
We take a localized approach to managing our subsidiaries, including provider and member services. This approach enables us to facilitate access by our members to high quality, culturally sensitive healthcare services. Our systems and procedures have been designed to address these community-specific challenges through outreach, education, transportation and other member support activities. For example, our community outreach programs work with our members and their communities to promote health and self-improvement through education on how best to access care. We complement this localized approach with a centralized infrastructure of support functions such as finance, information systems and claims processing, which allows us to minimize selling, general and administrative (SG&A) expenses and to integrate and realize synergies from acquisitions. We believe this combined approach allows us to efficiently integrate new business opportunities in both Medicaid and specialty services while maintaining our local accountability and improved access.
|
•
|
Quality and Innovation.
Our innovative medical management programs focus on improving quality of care in areas that have the greatest impact on our members. We concentrate on serving the whole person to impact outcomes and costs. We recognize the importance of member-focused delivery of quality managed care services and have developed award winning education and outreach programs including the CentAccount program, On.Demand Diabetes, Start Smart For Your Baby, and MemberConnections.
|
•
|
Increase Penetration of Existing State Markets.
We seek to continue to increase our Medicaid, Medicare and Health Insurance Marketplace membership in states in which we currently operate through alliances with key providers, outreach efforts, development and implementation of community-specific products and acquisitions. For example, in 2017, we began providing managed care services to MO HealthNet Managed Care beneficiaries under an expanded statewide contract. Also, in 2017, we expanded our Medicare Advantage footprint into four of our existing states. In 2018, we expanded Medicare Advantage further into nine of our existing states.
|
•
|
Diversify Business Lines.
We seek to broaden our business lines into areas that complement our existing business to enable us to grow and diversify our revenues. In 2017, we served managed care members in 27 states through approximately 300 product solutions. We are constantly evaluating new opportunities for expansion both domestically and abroad. For example, in 2016, we acquired Health Net, which broadened our service offerings and added government-sponsored care. We employ a disciplined acquisition strategy that is based on defined criteria including internal rate of return, accretion to earnings per share, market leadership and compatibility with our information systems. We engage our executives in the relevant operational units or functional areas to ensure consistency between the diligence and integration process.
|
•
|
Address Emerging State Needs.
We work to assist the states in which we operate in addressing the operating challenges they face. We seek to assist the states in balancing premium rates, benefit levels, member eligibility, policies and practices, provider compensation and minimizing fraud, waste, and abuse. By helping states structure appropriate programs to cover a wide range of populations including Medicaid, CHIP, LTSS, ABD, Intellectual or Developmental Disabilities (IDD), behavioral health and specialty services, among others. We seek to ensure that we are able to continue to provide those services on terms that achieve targeted gross margins, provide an acceptable return and grow our business.
|
•
|
Develop and Acquire Additional Markets.
We continue to leverage our experience to identify and develop new domestic and international markets by seeking both to acquire existing business and to build our own operations. Domestically, we focus expansion in states where Medicaid recipients are mandated to enroll in managed care organizations because we believe member enrollment levels are more predictable in these states. In addition, we provide solutions to states looking to deliver the highest quality of care within their budgetary constraints. In 2016, we increased our ownership interest to 75% in The Practice (Group) Limited (TPG), one of the largest provider networks for NHS England. In 2017, we expanded into Maryland, Nebraska and Nevada. Also in 2017, we signed a definitive agreement under which Fidelis Care will become our health plan in New York State.
|
•
|
Leverage Established Infrastructure to Enhance Operating Efficiencies
. We intend to continue to invest in infrastructure to further drive efficiencies in operations and to add functionality to improve the service provided to members and other organizations at a low cost. Information technology (IT) investments complement our overall efficiency goals by increasing the automated processing of transactions and growing the base of decision-making analytical tools. We believe that our centralized functions and common systems enable us to add members and markets quickly and economically.
|
•
|
Maintain Operational Discipline.
We seek to operate in markets that allow us to meet our internal metrics including membership growth, plan size, market leadership and operating efficiency. We use multiple techniques to monitor and reduce our medical costs, including on-site hospital review by staff nurses and involvement of medical management in significant cases. Our executive dashboard is utilized to quickly identify cost drivers and medical trends. Our management team regularly evaluates the financial impact of proposed changes in provider relationships, contracts, changes in membership and mix of members, potential state rate changes and cost reduction initiatives. We may divest contracts or health plans in markets where the environment, over a long-term basis, does not allow us to meet our targeted performance levels. For example, due to under performance, we exited the Arizona individual PPO business, effective January 1, 2017. In addition, in 2016, we took various rate and product design actions for 2017 to address issues and improve profitability in connection with certain lines of business acquired with the Health Net Acquisition.
|
•
|
Significant cost savings and budget predictability compared to state paid reimbursement for services.
We bring experience relating to quality of care improvement methods, utilization management procedures, an efficient claims payment system, and provider performance reporting, as well as managers and staff experienced in using these key elements to improve the quality of and access to care. We generally receive a contracted premium on a per member basis and are responsible for the medical costs and, as a result, provide budget predictability.
|
•
|
Data-driven approaches to balance cost and verify eligibility.
We seek to ensure effective outreach procedures for new members, then educate them and ensure they receive needed services as quickly as possible. Our IT department has created mapping/translation programs for loading membership and linking membership eligibility status to all of Centene's subsystems. We utilize predictive modeling technology to proactively case and disease manage specific high risk members. In addition, we have developed Centelligence, our enterprise data warehouse system to provide a seamless flow of data across our organization, enabling providers and case managers to access information, apply analytical insight and make informed decisions.
|
•
|
Establishment of realistic and meaningful expectations for quality deliverables.
We have collaborated with state agencies in redefining benefits, eligibility requirements and provider fee schedules with the goal of maximizing the number of individuals covered through Medicaid.
|
•
|
Managed care expertise in government subsidized programs.
Our expertise in Medicaid has helped us establish and maintain strong relationships with our constituent communities of members, providers and state governments. We provide access to services through local providers and staff that focus on the cultural norms of their individual communities. To that end, systems and procedures have been designed to address community-specific challenges through outreach, education, transportation and other member support activities.
|
•
|
Improved quality and medical outcomes.
We have implemented programs to enhance the ability of providers to improve the quality of healthcare delivered to our members including On.Demand Diabetes, Start Smart for your Baby, Living Well With Sickle Cell and The CentAccount Program.
|
•
|
Timely payment of provider claims.
We are committed to ensuring that our information systems and claims payment systems meet or exceed state requirements. We continuously endeavor to update our systems and processes to improve the timeliness of our provider payments.
|
•
|
Provider outreach and programs.
Our health plans have adopted a physician-driven approach where network providers are actively engaged in developing and implementing healthcare delivery policies and strategies. We prepare provider comparisons on a severity adjusted basis. This approach is designed to eliminate unnecessary costs, improve services to members and simplify the administrative burdens placed on providers.
|
•
|
Care management for complex populations.
Through our experience with Medicaid populations and long-time presence in states with experience in long-term care for children and adolescents in the foster care system, we have developed care management, service coordination and crisis prevention/response programs that increase opportunities for successful outcomes for members. This experience has led to partnerships with specialized networks and community advocates as states transition to managed care programs for vulnerable and complex populations.
|
•
|
Responsible collection and dissemination of utilization data.
We gather utilization data from multiple sources, allowing for an integrated view of our members' utilization of services. These sources include medical, vision and behavioral health claims and encounter data, pharmacy data, dental vendor claims and authorization data from the authorization and case management system utilized by us to coordinate care.
|
•
|
Timely and accurate reporting.
Our information systems have reporting capabilities which have been instrumental in identifying the need for new and/or improved healthcare and specialty programs. For state agencies, our reporting capability is important in demonstrating an auditable program.
|
•
|
Fraud, waste and abuse prevention.
We have several systems in place to help identify, detect and investigate potential waste, abuse and fraud including pre and post payment review software. We collaborate with state and federal agencies and assist with investigation requests. We use nationally recognized standards to benchmark our processes.
|
•
|
primary and specialty physician care
|
•
|
inpatient and outpatient hospital care
|
•
|
emergency and urgent care
|
•
|
prenatal care
|
•
|
laboratory and x-ray services
|
•
|
home-based primary care
|
•
|
transportation assistance
|
•
|
vision care
|
•
|
dental care
|
•
|
immunizations
|
•
|
prescriptions and limited over-the-counter drugs
|
•
|
specialty pharmacy
|
•
|
provision of durable medical equipment
|
•
|
behavioral health and substance abuse services
|
•
|
24-hour nurse advice line
|
•
|
therapies
|
•
|
social work services
|
•
|
care coordination
|
•
|
Start Smart For Your Baby,
or Start Smart,
is our award winning prenatal and infant health program designed to increase the percentage of pregnant women receiving early prenatal care, reduce the incidence of low-birth-weight babies, identify high-risk pregnancies, increase participation in the federal Women, Infant and Children program, prevent hospital admissions in the first year of life and increase well-child visits.
|
•
|
Connections Plus
is a cell phone program developed for high-risk members who have limited or no safe and reliable access to telephone. This program seeks to eliminate lack of safe, reliable access to a telephone as a barrier to coordinating care, thus reducing avoidable adverse events such as inappropriate emergency room utilization, hospital admissions and premature birth.
|
•
|
MemberConnections
is a community face-to-face outreach and education program designed to create a link between the member and the provider and help identify potential challenges or risk elements to a member's health, such as nutritional challenges and health education shortcomings.
|
•
|
The ScriptAssist for Hepatitis C Adherence Program
seeks to empower patients towards Hepatitis C virus treatment success through a series of telephonic interventions. Goals of the program include preventing premature treatment discontinuation due to medication side effects and access to therapy. Through its family of companies, Envolve clinicians and AcariaHealth patient care coordinators collaborate throughout a patient’s treatment course to ensure appropriate therapy management and regimen access.
|
•
|
Health Initiatives for Children
is aimed at educating child members on a variety of health topics. In order to empower and educate children, we have partnered with a nationally recognized children's author to develop our own children's book series on topics such as obesity prevention and healthy eating, asthma, diabetes, foster care, the ills of smoking, anti-bullying and heart health.
|
•
|
Health Initiatives for Teens
is aimed at empowering, educating and reinforcing life skills with our teenage members. We have developed an educational series that addresses health issues, dealing with chronic diseases including diabetes and asthma, as well as teen pregnancy.
|
•
|
Living Well with Sickle Cell
is our innovative program that assists with coordination of care for our sickle cell members. Our program ensures that sickle cell members have established a medical home and work on strategies to reduce unnecessary emergency room visits through proper treatment to control symptoms and chronic complications, as well as promote self-management.
|
•
|
My Route for Health
is our adult educational series used with our case management and disease management programs. The topics of this series include how to manage asthma, Chronic Obstructive Pulmonary Disease (COPD), diabetes, heart disease and HIV.
|
•
|
The Diabetes Management Program
is a robust holistic program designed to improve the quality of life for our members living with diabetes. The program employs advanced analytics to identify members and provide individualized diabetes-related education and health assessments, support with self-management, and assistance accessing care.
|
•
|
On.Demand Diabetes
is a diabetes management support product designed to eliminate diabetic supply waste while increasing compliance and improving health outcomes for members with diabetes. On.Demand provides cellular-enabled blood glucose meters and test strips to the testing diabetic population. On.Demand automatically monitors all member tests and provides an appropriate level of intervention in the event of dangerous glucose readings or member non-compliance. Additionally, On.Demand’s proprietary algorithm analyzes each member’s testing patterns and automatically replenishes testing supplies to ensure there are no gaps in the member’s ability to effectively monitor their condition.
|
•
|
Community Health Record,
our patient-centric electronic database, collects patient demographic data, clinician visit records, dispensed medications, vital sign history, lab results, allergy charts, and immunization data. Providers can directly input additional or updated patient data and documentation into the database. All information is accessible anywhere, anytime to all authorized users, including health plan staff, greatly facilitating coordinated care among providers.
|
•
|
The CentAccount Program
offers members financial incentives for performing certain healthy behaviors. The incentives are delivered through a restricted-use prepaid debit card. This incentive-based approach effectively increases the utilization of preventive services while strengthening the relationships between members and their primary care providers.
|
•
|
The Asthma Management Program
integrates a hands-on approach with a flexible outreach methodology that can be customized to suit different age groups and populations affected by asthma. We provide proactive identification of members, stratification into appropriate levels of intervention including home visits, culturally sensitive education, and robust outcome reporting. The program also includes aggressive care coordination to ensure patients have basic services such as transportation to the doctor, electricity to power the nebulizer, and a clean, safe home environment.
|
•
|
Fluvention
is an outreach program aimed at educating members on preventing the transmission of the influenza virus by encouraging members to get the seasonal influenza vaccines and take everyday precautions to prevent illness.
|
•
|
Preventive Care Programs
are designed to educate our members on the benefits of Early and Periodic Screening, Diagnosis and Treatment, or EPSDT, services. We have a systematic program of communicating, tracking, outreach, reporting and follow-through that promotes state EPSDT programs.
|
•
|
Readmission Reduction Program
utilizes a proprietary scoring methodology to evaluate members' risks on preventable readmissions. Members with higher risk scores are identified at the point of admission to an acute care setting, then concurrently managed during the in-patient stay, and followed up with post discharge outreach to provide effective transition of care.
|
•
|
Clinical Programs Library (CPL)
is a highly collaborative initiative that empowers partners across the organization to develop evidence based clinical programs to promote best practice information sharing, and to establish measurable outcomes for clinical studies. The CPL also serves as a repository of enterprise pilots and programs intended to improve the member's health outcomes.
|
•
|
Promotores Health Network (PHN)
is a volunteer-driven community health network designed to improve the community's health through health education specific to health conditions impacting their community and providing guidance and linkage to healthcare services and local resources. PHN provides face-to-face education to members where they live, shop, worship and congregate.
|
•
|
myStrength ("The health club for your mind")
is a web and mobile self-help resource to manage depression, anxiety, substance use, and chronic pain. myStrength empowers members to be active participants in their journey to becoming and staying mentally and physically healthy.
|
•
|
Opioid Risk Classification Algorithm (ORCA)
is designed to identify members at risk for an opioid abuse diagnosis based on a series of critical social and clinical indicators. Providers will leverage this risk score to flag members for case management and other appropriate interventions. High risk members identified by ORCA will receive educational outreach to provide evidenced-based resources to support pain addiction.
|
•
|
Under our fee-for-service contracts with providers, we pay a negotiated fee for covered services. This model is characterized as having no financial risk for the provider.
|
•
|
Under our capitated contracts, providers can be paid a set amount for their services as outlined in their respective provider agreements. A provider group's financial instability or failure to pay secondary providers for services rendered could lead secondary providers to demand payment from us, even though we have made our regular capitated payments to the provider group. Depending on state law and the regulatory environment, it may be necessary for us to pay such claims.
|
•
|
Under value-based arrangements, providers are paid under a capitated or fee-for-service arrangement. The arrangement, however, contains provisions for additional payments to the providers or reimbursement from the providers based upon cost and quality measures.
|
•
|
Provider Engagement Performance Tools and Processes
lead to measurable improvements in quality and health outcomes, healthcare costs, and member satisfaction. High quality and performance levels are important as our key customers are increasingly using performance-based measures to select and pay health plans. We have rolled out a suite of network performance tools for use by physicians and other providers which monitor the outcomes and care gaps of their individual patient panel. Our specialists meet with the providers to review their performance issues and recommend strategies for improvements in their patient panel outcomes. Our tools also allow the physician and others to see where they stand within their value-based contract.
|
•
|
Integrated Care Model
is member-centric and managed by one care manager assigned to a member who looks at the total care for the member in a holistic manner. This single care manager will coordinate all care for that member including behavioral health, medical health, and home-based primary care in accordance with an individualized, integrated care plan. This care manager also coordinates meetings with the member's integrated care team to assess and alter the care plan as needed. This results in better outcomes and improvement in member satisfaction.
|
•
|
Provider Portal
provides claims and eligibility research, prior authorizations, member panels, care gaps, patient analytics, and provider analytics meant to drive provider engagement and better patient outcomes. Performance is supplied via a secure, user-friendly web-based provider portal.
|
•
|
use of nationally recognized Interqual or Milliman criteria to help ensure our members receive the right level of care in the most appropriate setting;
|
•
|
pre-authorized high-risk mediation and services that are commonly over or inappropriately prescribed;
|
•
|
member education and the provision of appropriate and easily accessed urgent care services to help members avoid unnecessary and costly emergency room visits and improve their healthcare experience;
|
•
|
emphasis on care management and care coordination where clinicians, such as nurses and social workers who are employed to assist high-risk and other selected members with the coordination of healthcare services that meet their specific needs;
|
•
|
disease management for chronic illnesses, such as asthma and diabetes through a comprehensive, multidisciplinary and collaborative approach;
|
•
|
prenatal case management for women with high-risk pregnancies to help them deliver full, healthy infants; and
|
•
|
pharmacy treatment compliance programs driven by evidence-based clinical policies and focused on identifying the appropriate medication in the correct dose, delivered in an efficient format and utilized for the correct duration.
|
•
|
Pharmacy Solutions.
Envolve Pharmacy Solutions utilizes innovative, flexible solutions and customized care management. We offer traditional pharmacy benefits management as well as comprehensive specialized pharmacy benefit services through our specialty pharmacy, AcariaHealth. Our traditional pharmacy benefits management program offers progressive pharmacy benefits management services that are specifically designed to improve quality of care while containing costs. This is achieved through a low cost strategy that helps optimize clients' pharmacy benefits. Services that we provide include claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, online drug management tools, mail order pharmacy services, home delivery services, analytics and clinical consulting and patient and physician intervention. AcariaHealth offers specialized care management services for complex diseases and enhances the patient care offering through collaboration with providers and the capture of relevant data to measure patient outcomes.
|
•
|
Health, Triage, Wellness, and Disease Management Services
. Envolve PeopleCare brings together our behavioral health, nurse advice, telehealth, and health, wellness and disease guidance programs, allowing for a focus on individual health management through education and empowerment. Our life and health management programs specialize to encourage healthy behaviors, promote healthier workplaces, improve workforce and societal productivity and reduce healthcare costs. We offer telehealth services where members engage with customer service representatives and nursing staff who provide health education and triage advice and offer continuous access to health plan functions. Our staff can arrange for urgent pharmacy refills, transportation and qualified behavioral health professionals for crisis stabilization assessments.
|
•
|
Vision and Dental Services.
Envolve Benefit Options coordinates benefits beyond traditional medical benefits to offer fully integrated vision and dental health services. Our vision benefit program administers routine and medical surgical eye care benefits through a contracted national network of eye care providers. Through the dental benefit, we are dedicated to improving oral health through a contracted network of dental healthcare providers.
|
•
|
Care Management Software.
Casenet is a software provider of innovative care management solutions that automate the clinical, administrative and technical components of care management programs, which is used by our health plans and available for sale to third parties.
|
•
|
Correctional Healthcare Services.
Centurion, our joint venture subsidiary with MHM Services Inc., provides comprehensive healthcare services to individuals incarcerated in Florida, Massachusetts, Minnesota, Mississippi, New Mexico, Tennessee and Vermont state correctional facilities.
|
•
|
Home-based Primary Care.
U.S. Medical Management (USMM) provides home-based primary care services for high acuity populations and participates as an Accountable Care Organization (ACO) through the CMS Medicare Shared Savings Program.
|
•
|
Integrated Long-Term Care.
LifeShare provides home and community-based support for people with intellectual and developmental disabilities, children in the child welfare system and people of all ages and abilities, with a focus on those that are often marginalized by society. In addition, LifeShare operates school-based programs that focus on students with special needs.
|
•
|
Management Services.
Envolve provides comprehensive management services for managed care organizations and partners with organizations to offer coordinated healthcare services and programs to their members.
|
•
|
Federal Services
. Health Net Federal Services (HNFS) has a Managed Support Contract in the West Region for the DoD TRICARE program. The services that are provided are structured as cost reimbursement arrangements for healthcare costs plus administrative fees received in the form of fixed prices, fixed unit prices, and contingent fees and payments based on various incentives and penalties. We provide administrative services to Military Health System eligible beneficiaries, which includes eligible active duty service members and their families, retired service members and their families, survivors of retired service members and qualified former spouses. HNFS also supports the PC3 program, which provides eligible veterans coordinated, timely access to care through a comprehensive network of non-VA providers who meet VA quality standards when a local VA medical center cannot readily provide the care. Additionally, our wholly owned subsidiary, MHN Government Services, is party to a MFLC contract that was awarded by the DoD to implement, administer and monitor the non-medical counseling MFLC program.
|
•
|
written standards of conduct;
|
•
|
designation of compliance officers and compliance committees;
|
•
|
effective training and education;
|
•
|
effective lines for reporting and communication;
|
•
|
enforcement of standards through well publicized disciplinary guidelines and actions;
|
•
|
internal monitoring and auditing; and
|
•
|
prompt response to detected offenses and development of corrective action plans.
|
•
|
Medicaid Managed Care Organizations
that focus on providing healthcare services to Medicaid recipients. These organizations consist of national and regional organizations, as well as not-for-profits and smaller organizations that operate in one city or state and are owned by providers, primarily hospitals.
|
•
|
National and Regional Commercial Managed Care Organizations
that have Medicaid and Medicare members in addition to members in private commercial plans. Some of these organizations offer a range of specialty services including pharmacy benefits management, behavioral health management, health management, and nurse triage call support centers.
|
•
|
Primary Care Case Management Programs
that are established by the states through contracts with primary care providers. Under these programs, physicians provide primary care services to Medicaid recipients, as well as limited medical management oversight.
|
•
|
Accountable Care Organizations
that consist of groups of doctors, hospitals, and other healthcare providers, who come together to give coordinated high quality care to their patients.
|
•
|
premium taxes or similar assessments imposed on us;
|
•
|
stringent prompt payment laws requiring us to pay claims within a specified period of time;
|
•
|
disclosure requirements regarding provider fee schedules and coding procedures; and
|
•
|
programs to monitor and supervise the activities and financial solvency of provider groups.
|
•
|
eligibility, enrollment and dis-enrollment processes
|
•
|
covered services
|
•
|
eligible providers
|
•
|
subcontractors
|
•
|
record-keeping and record retention
|
•
|
periodic financial and informational reporting
|
•
|
quality assurance
|
•
|
accreditation
|
•
|
health education and wellness and prevention programs
|
•
|
timeliness of claims payment
|
•
|
financial standards
|
•
|
safeguarding of member information
|
•
|
fraud, waste and abuse detection and reporting
|
•
|
grievance procedures
|
•
|
organization and administrative systems
|
Name
|
|
Age
|
|
Position
|
|
Michael F. Neidorff
|
|
75
|
|
|
Chairman and Chief Executive Officer
|
Christopher D. Bowers
|
|
62
|
|
|
Executive Vice President, Markets
|
Cynthia J. Brinkley
|
|
58
|
|
|
President and Chief Operating Officer
|
Mark J. Brooks
|
|
48
|
|
|
Executive Vice President and Chief Information Officer
|
Jesse N. Hunter
|
|
42
|
|
|
Executive Vice President and Chief Strategy Officer
|
Christopher R. Isaak
|
|
51
|
|
|
Senior Vice President, Corporate Controller and Chief Accounting Officer
|
Jeffrey A. Schwaneke
|
|
42
|
|
|
Executive Vice President, Chief Financial Officer and Treasurer
|
Keith H. Williamson
|
|
65
|
|
|
Executive Vice President, General Counsel and Secretary
|
•
|
the diversion of management’s attention from ongoing business concerns and performance shortfalls as a result of the devotion of management’s attention to the integration;
|
•
|
managing a larger combined company;
|
•
|
maintaining employee morale and retaining key management and other employees;
|
•
|
the possibility of faulty assumptions underlying expectations regarding the integration process;
|
•
|
retaining existing business and operational relationships and attracting new business and operational relationships;
|
•
|
consolidating corporate and administrative infrastructures and eliminating duplicative operations;
|
•
|
coordinating geographically separate organizations;
|
•
|
unanticipated issues in integrating information technology, communications and other systems;
|
•
|
unanticipated changes in federal or state laws or regulations, including changes with respect to government healthcare programs, the ACA and any regulations enacted thereunder; and
|
•
|
unforeseen expenses or delays associated with the acquisition and/or integration.
|
•
|
the market price of our common stock could decline;
|
•
|
if the asset purchase agreement is terminated and our board of directors (Board) seeks another business combination, our stockholders cannot be certain that we will be able to find a party willing to enter into any transaction on terms equivalent to or more attractive than the terms that we and Fidelis Care have agreed to in the asset purchase agreement;
|
•
|
time and resources committed by our management to matters relating to the Proposed Fidelis Acquisition could otherwise have been devoted to pursuing other beneficial opportunities;
|
•
|
we may experience negative reactions from the financial markets or from our customers or employees; and
|
•
|
we will be required to pay our costs relating to the Proposed Fidelis Acquisition, such as legal, accounting, financial advisory and printing fees, whether or not the Proposed Fidelis Acquisition is completed.
|
•
|
the diversion of management’s attention from ongoing business concerns and performance shortfalls at one or both of the companies as a result of the devotion of management’s attention to the Proposed Fidelis Acquisition;
|
•
|
managing a larger combined company;
|
•
|
maintaining employee morale and retaining key management and other employees;
|
•
|
the possibility of faulty assumptions underlying expectations regarding the integration process;
|
•
|
retaining existing business and operational relationships and attracting new business and operational relationships;
|
•
|
consolidating corporate and administrative infrastructures and eliminating duplicative operations;
|
•
|
coordinating geographically separate organizations;
|
•
|
unanticipated issues in integrating information technology, communications and other systems;
|
•
|
unanticipated changes in federal or state laws or regulations, including the ACA and any regulations enacted thereunder;
|
•
|
decreases in premiums paid under government sponsored healthcare programs by any state in which the combined company operates; and
|
•
|
unforeseen expenses or delays associated with the Proposed Fidelis Acquisition.
|
•
|
affecting our ability to pay or refinance its debts as they become due during adverse economic, financial market and industry conditions;
|
•
|
requiring us to use a larger portion of its cash flow for debt service, reducing funds available for other purposes;
|
•
|
causing us to be less able to take advantage of business opportunities, such as acquisition opportunities, and to react to changes in market or industry conditions;
|
•
|
increasing our vulnerability to adverse economic, industry or competitive developments;
|
•
|
affecting our ability to obtain additional financing;
|
•
|
decreasing our profitability and/or cash flow;
|
•
|
causing us to be disadvantaged compared to competitors with less leverage;
|
•
|
resulting in a downgrade in our credit rating or any of our indebtedness or our subsidiaries which could increase the cost of further borrowings; and
|
•
|
limiting our ability to borrow additional funds in the future to fund working capital, capital expenditures and other general corporate purposes.
|
•
|
payments in respect of, or redemptions or acquisitions of, debt or equity issued by the combined company or its subsidiaries, including the payment of dividends on our common stock;
|
•
|
incurring additional indebtedness;
|
•
|
incurring guarantee obligations;
|
•
|
paying dividends;
|
•
|
creating liens on assets;
|
•
|
entering into sale and leaseback transactions;
|
•
|
making investments, loans or advances;
|
•
|
entering into hedging transactions;
|
•
|
engaging in mergers, consolidations or sales of all or substantially all of their respective assets; and
|
•
|
engaging in certain transactions with affiliates.
|
|
2018 Stock Price (through
February 16, 2018)
|
|
2017 Stock Price
|
|
2016 Stock Price
|
||||||||||||||||||
|
High
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||||||
First Quarter
|
$
|
112.42
|
|
|
$
|
97.61
|
|
|
$
|
73.23
|
|
|
$
|
56.00
|
|
|
$
|
68.42
|
|
|
$
|
47.36
|
|
Second Quarter
|
|
|
|
|
85.80
|
|
|
69.20
|
|
|
71.53
|
|
|
55.60
|
|
||||||||
Third Quarter
|
|
|
|
|
98.72
|
|
|
79.06
|
|
|
75.57
|
|
|
63.37
|
|
||||||||
Fourth Quarter
|
|
|
|
|
104.65
|
|
|
83.56
|
|
|
67.41
|
|
|
50.00
|
|
Issuer Purchases of Equity Securities
Fourth Quarter 2017
(shares in thousands)
|
|||||||||||
Period
|
|
Total Number of
Shares
Purchased
(1)
|
|
Average Price
Paid per
Share
|
|
Total Number
of Shares
Purchased as
Part of Publicly
Announced Plans
or Programs
|
|
Maximum
Number of Shares
that May Yet Be
Purchased Under
the Plans or
Programs
(2)
|
|||
October 1 – October 31, 2017
|
|
6
|
|
$
|
91.63
|
|
|
—
|
|
|
3,335
|
November 1 – November 30, 2017
|
|
12
|
|
93.24
|
|
|
—
|
|
|
3,335
|
|
December 1 – December 31, 2017
|
|
456
|
|
100.36
|
|
|
—
|
|
|
3,335
|
|
Total
|
|
474
|
|
$
|
100.07
|
|
|
—
|
|
|
3,335
|
|
|
|
|
|
|
|
|
|
|||
(1) Shares acquired represent shares relinquished to the Company by certain employees for payment of taxes or option cost upon vesting of restricted stock units or option exercise.
|
|||||||||||
(2) Our Board of Directors adopted a stock repurchase program which allows for repurchases of up to a remaining amount of 3 million shares. No duration has been placed on the repurchase program.
|
|
December 31,
|
||||||||||||||||||||||
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
||||||||||||
Centene Corporation
|
$
|
100.00
|
|
|
$
|
143.80
|
|
|
$
|
253.32
|
|
|
$
|
321.02
|
|
|
$275.66
|
|
$
|
492.10
|
|
||
New York Stock Exchange Composite Index
|
100.00
|
|
|
123.18
|
|
|
128.37
|
|
|
120.13
|
|
|
130.95
|
|
|
151.70
|
|
||||||
S&P Supercomposite Managed Healthcare Index
|
100.00
|
|
|
145.12
|
|
|
193.00
|
|
|
231.69
|
|
|
273.88
|
|
|
389.61
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Centene Corporation closing stock price
|
$
|
20.50
|
|
|
$
|
29.48
|
|
|
$
|
51.93
|
|
|
$
|
65.81
|
|
|
$
|
56.51
|
|
|
$
|
100.88
|
|
Centene Corporation annual shareholder return
|
3.5
|
%
|
|
43.8
|
%
|
|
76.2
|
%
|
|
26.7
|
%
|
|
(14.1
|
)%
|
|
78.5
|
%
|
•
|
Year-end managed care membership of
12.2 million
, an increase of
765,300
members, or
7%
over
2016
.
|
•
|
Total revenues of
$48.4 billion
, representing
19%
growth year-over-year.
|
•
|
HBR of
87.3%
for
2017
, compared to
86.5%
for
2016
.
|
•
|
SG&A expense ratio of
9.7%
for
2017
, compared to
9.8%
for
2016
.
|
•
|
Adjusted SG&A expense ratio of
9.5%
for
2017
, compared to
9.0%
for
2016
.
|
•
|
Operating cash flows of
$1,489 million
, or
1.8
times net earnings, for 2017.
|
•
|
Diluted EPS of
$4.69
for
2017
, compared to
$3.41
for
2016
.
|
•
|
Adjusted Diluted EPS of
$5.03
for
2017
, compared to
$4.43
for
2016
.
|
|
Year Ended December 31,
|
|||||||
|
2017
|
|
2016
|
|
||||
|
|
|
|
|
||||
GAAP diluted EPS from continuing operations
|
$
|
4.69
|
|
|
$
|
3.41
|
|
|
Amortization of acquired intangible assets
|
0.56
|
|
|
0.57
|
|
|
||
Acquisition related expenses
|
0.07
|
|
|
0.98
|
|
|
||
Penn Treaty assessment expense
|
0.20
|
|
|
—
|
|
|
||
Cost sharing reductions
|
0.08
|
|
|
—
|
|
|
||
Income Tax Reform
|
(0.71
|
)
|
|
—
|
|
|
||
Charitable contribution
|
0.14
|
|
|
0.19
|
|
|
||
California minimum MLR change
|
—
|
|
|
(0.76
|
)
|
|
||
Debt extinguishment
|
—
|
|
|
0.04
|
|
|
||
Adjusted Diluted EPS from continuing operations
|
$
|
5.03
|
|
|
$
|
4.43
|
|
|
•
|
Arizona.
In January 2017, we continued our participation as a qualified health plan issuer in the Arizona Health Insurance Marketplace and exited the Health Net preferred provider organization offerings in Arizona.
|
•
|
Centurion.
In April 2016, Centurion began providing correctional healthcare services for the Florida Department of Corrections in three regions. In June 2016, Centurion began operating under two new contracts with the State of New Mexico Corrections Department to provide correctional medical healthcare services and pharmacy services. In June 2017, Centurion began operating under an expanded contract to provide correctional healthcare services for the Florida Department of Corrections in South Florida, expanding our services statewide.
|
•
|
Health Insurance Marketplace
. In January 2017, we added over 500,000 new members across our Health Insurance Marketplace service areas.
|
•
|
Health Net.
On March 24, 2016, we acquired all of the issued and outstanding shares of Health Net for approximately $6.0 billion, including the assumption of debt. This strategic acquisition broadened our service offerings, providing expansion in both Medicaid and Medicare programs. This acquisition provided further diversification across our markets and products through the addition of commercial products and government-sponsored care under federal contracts with the Department of Defense (DoD) and the U.S. Department of Veteran's Affairs (VA), as well as Medicare Advantage. Health Net's operations are primarily concentrated in the states of California, Arizona, Oregon, and Washington.
|
•
|
Louisiana.
In July 2016, Louisiana Healthcare Connections began serving Medicaid expansion members.
|
•
|
Maryland.
In July 2017, our specialty solutions subsidiary, Envolve, Inc., began providing health plan management services for Medicaid operations in Maryland.
|
•
|
Missouri.
In May 2017, our Missouri subsidiary, Home State Health, began providing managed care services to MO HealthNet Managed Care beneficiaries under an expanded statewide contract.
|
•
|
Nebraska.
In January 2017, our Nebraska subsidiary, Nebraska Total Care, began operating under a contract with the Nebraska Department of Health and Human Services' Division of Medicaid and Long-Term Care as one of three managed care organizations to administer its new Heritage Health Program for Medicaid, ABD, CHIP, Foster Care and LTSS enrollees.
|
•
|
Nevada.
In July 2017, our Nevada subsidiary, SilverSummit Healthplan, began serving Medicaid recipients enrolled in Nevada's Medicaid managed care program.
|
•
|
New Hampshire.
In January 2016, we began serving members enrolled in the federally facilitated Health Insurance Marketplace in the State of New Hampshire. In January 2016, we started operating under a contract with the New Hampshire Department of Health and Human Services to participate in the Medicaid expansion model that New Hampshire has adopted (referred to as the “Premium Assistance Program”).
|
•
|
Texas.
In November 2016, our Texas subsidiary, Superior HealthPlan, Inc., began operating under a new contract with the Texas HHSC to serve STAR Kids Medicaid population in seven delivery areas, more than any other successful bidder.
|
•
|
Washington.
In April 2016, our Washington subsidiary, Coordinated Care of Washington, began operating as the sole contractor with the Washington State Health Care Authority to provide foster care services through the Apple Health Foster Care contract.
|
•
|
In Georgia and Indiana, we were recently successful in reprocuring contracts. However, the Medicaid programs were expanded to include additional insurers, which has reduced our market share. In addition, we are no longer serving LTSS members in Arizona.
|
•
|
We expect to realize the full year benefit in 2018 of business commenced during 2017 in Florida, Maryland, Missouri and Nevada, as discussed above.
|
•
|
In February 2018, our Arkansas subsidiary, Arkansas Total Care began managing a Medicaid special needs population comprised of people with high behavioral health needs and individuals with developmental/intellectual disabilities. Arkansas Total Care will assume full-risk on this population beginning in January 2019.
|
•
|
In January 2018, our New Mexico subsidiary, Western Sky Community Care, was awarded a statewide contract in New Mexico for the Centennial Care 2.0 Program. The new contract is expected to commence membership operations in January 2019.
|
•
|
In January 2018, our Illinois subsidiary, IlliniCare Health, began operating under a state-wide contract for the Medicaid Managed Care Program including children who are in need through the Department of Children and Family Services (DCFS)/Youth in Care by the Illinois Department of Healthcare and Family Services (HFS). Implementation dates vary by region and will be fully implemented statewide by April 2018. Foster Care will be implemented by July 2018.
|
•
|
In January 2018, we expanded our offerings in the 2018 Health Insurance Marketplace. We entered Kansas, Missouri and Nevada, and expanded our footprint in the following six existing markets: Florida, Georgia, Indiana, Ohio, Texas, and Washington.
|
•
|
In January 2018, we expanded our offerings in Medicare. We entered Arkansas, Indiana, Kansas, Louisiana, Missouri, Pennsylvania, South Carolina, and Washington and expanded our footprint in Ohio.
|
•
|
In January 2018, our subsidiary, Health Net Federal Services, began operating under the TRICARE West Region contract to provide administrative services to Military Health System eligible beneficiaries.
|
•
|
In January 2018, our Washington subsidiary, Coordinated Care of Washington, began providing managed care services to Apple Health's Fully Integrated Managed Care (FIMC) beneficiaries in the North Central Region.
|
•
|
In January 2018, our Pennsylvania subsidiary, Pennsylvania Health & Wellness, began serving enrollees in the Community HealthChoices program. Contract commencement dates vary by zone and will be fully implemented statewide by January 2020.
|
•
|
In September 2017, we signed a definitive agreement under which Fidelis Care will become our health plan in New York State upon closing. Under the terms of the agreement, we will acquire substantially all of the assets of Fidelis Care for $3.75 billion, subject to certain adjustments. This transaction is expected to close in the second quarter of 2018, subject to various closing conditions and receipt of New York regulatory approvals, including approvals under the New York Not-for-Profit Corporation Law.
|
•
|
In August 2017, Centurion was recommended for a contract award by the Tennessee Department of Correction to continue providing inmate health services. This contract is expected to commence in the third quarter of 2018.
|
•
|
In June 2017, our Mississippi subsidiary, Magnolia Health, was selected by the Mississippi Division of Medicaid to continue serving Medicaid recipients enrolled in the Mississippi Coordinated Access Network (MississippiCAN). Pending regulatory approval, the new three-year agreement, which also includes the option of two one-year extensions, is expected to commence mid-2018.
|
•
|
In January 2017, we signed a joint venture agreement with the North Carolina Medical Society, working in conjunction with the North Carolina Community Health Center Association, to collaborate on a patient-focused approach to Medicaid under the reform plan enacted in the State of North Carolina. The newly created health plan, Carolina Complete Health, was created to establish, organize and operate a physician-led health plan to provide Medicaid managed care services in North Carolina.
|
•
|
In January 2018, the State of California will no longer include costs for in-home support services (IHSS) in its Medicaid contracts. In June 2017, the governor approved the removal of these services from managed care and returned responsibility for the IHSS program costs back to the counties.
|
•
|
In addition, we will no longer be serving Medicaid members in Massachusetts.
|
|
December 31,
|
|||||||
|
2017
|
|
2016
|
|
2015
|
|||
Arizona
|
640,500
|
|
|
598,300
|
|
|
440,900
|
|
Arkansas
|
85,700
|
|
|
58,600
|
|
|
41,900
|
|
California
|
2,877,800
|
|
|
2,973,500
|
|
|
186,000
|
|
Florida
|
848,800
|
|
|
716,100
|
|
|
510,400
|
|
Georgia
|
483,600
|
|
|
488,000
|
|
|
408,600
|
|
Illinois
|
239,500
|
|
|
237,700
|
|
|
207,500
|
|
Indiana
|
304,500
|
|
|
285,800
|
|
|
282,100
|
|
Kansas
|
129,100
|
|
|
139,700
|
|
|
141,000
|
|
Louisiana
|
485,500
|
|
|
472,800
|
|
|
381,900
|
|
Massachusetts
|
43,000
|
|
|
48,300
|
|
|
61,500
|
|
Michigan
|
2,500
|
|
|
2,000
|
|
|
4,800
|
|
Minnesota
|
9,400
|
|
|
9,400
|
|
|
9,600
|
|
Mississippi
|
329,900
|
|
|
310,200
|
|
|
302,200
|
|
Missouri
|
269,400
|
|
|
105,700
|
|
|
95,100
|
|
Nebraska
|
79,700
|
|
|
—
|
|
|
—
|
|
Nevada
|
34,900
|
|
|
—
|
|
|
—
|
|
New Hampshire
|
74,800
|
|
|
77,400
|
|
|
71,400
|
|
New Mexico
|
7,100
|
|
|
7,100
|
|
|
—
|
|
Ohio
|
332,700
|
|
|
316,000
|
|
|
302,700
|
|
Oregon
|
205,200
|
|
|
217,800
|
|
|
98,700
|
|
South Carolina
|
117,800
|
|
|
122,500
|
|
|
104,000
|
|
Tennessee
|
22,200
|
|
|
21,700
|
|
|
20,000
|
|
Texas
|
1,233,500
|
|
|
1,072,400
|
|
|
983,100
|
|
Vermont
|
1,600
|
|
|
1,600
|
|
|
1,700
|
|
Washington
|
237,800
|
|
|
238,400
|
|
|
209,400
|
|
Wisconsin
|
70,200
|
|
|
73,800
|
|
|
77,100
|
|
Total at-risk membership
|
9,166,700
|
|
|
8,594,800
|
|
|
4,941,600
|
|
TRICARE eligibles
|
2,824,100
|
|
|
2,847,000
|
|
|
—
|
|
Non-risk membership
|
216,300
|
|
|
—
|
|
|
166,300
|
|
Total
|
12,207,100
|
|
|
11,441,800
|
|
|
5,107,900
|
|
•
|
membership growth in our Health Insurance Marketplace service areas;
|
•
|
the commencement of health plan management services for Medicaid operations in Maryland;
|
•
|
an expanded statewide managed care contract in Missouri; and
|
•
|
the commencement of new managed care contracts in Nebraska and Nevada.
|
•
|
the acquisition of Health Net;
|
•
|
organic growth in many of our states, including Florida, Georgia, Oregon, and Texas;
|
•
|
product and geographic expansions in Louisiana and Washington;
|
•
|
market growth and additional penetration in the Health Insurance Marketplace, which included a private option Medicaid expansion in New Hampshire; and
|
•
|
the commencement of correctional healthcare service contracts in Florida and New Mexico.
|
•
|
a full year of the Health Net business in our 2017 results;
|
•
|
the impact of new programs in many of our states in 2016 and 2017;
|
•
|
higher business expansion costs;
|
•
|
additional expense recognized for our estimated share of the undiscounted guaranty association assessment resulting from the liquidation of Penn Treaty; and
|
•
|
higher variable compensation expenses based on the performance of the business in 2017.
|
|
2017
|
|
2016
|
||||
Investment income
|
$
|
187
|
|
|
$
|
109
|
|
Earnings from equity method investments
|
3
|
|
|
5
|
|
||
Interest expense
|
(255
|
)
|
|
(217
|
)
|
||
Other income (expense), net
|
$
|
(65
|
)
|
|
$
|
(103
|
)
|
|
2017
|
|
2016
|
|
% Change
2016-2017 |
|||||
Total Revenues
|
|
|
|
|
|
|||||
Managed Care
|
$
|
45,842
|
|
|
$
|
38,382
|
|
|
19
|
%
|
Specialty Services
|
12,055
|
|
|
8,377
|
|
|
44
|
%
|
||
Eliminations
|
(9,515
|
)
|
|
(6,152
|
)
|
|
(55
|
)%
|
||
Consolidated Total
|
$
|
48,382
|
|
|
$
|
40,607
|
|
|
19
|
%
|
Earnings from Operations
|
|
|
|
|
|
|
|
|
||
Managed Care
|
$
|
917
|
|
|
$
|
1,077
|
|
|
(15
|
)%
|
Specialty Services
|
282
|
|
|
183
|
|
|
54
|
%
|
||
Consolidated Total
|
$
|
1,199
|
|
|
$
|
1,260
|
|
|
(5
|
)%
|
|
2016
|
|
2015
|
||||
Investment income
|
$
|
109
|
|
|
$
|
27
|
|
Earnings from equity method investments
|
5
|
|
|
8
|
|
||
Interest expense
|
(217
|
)
|
|
(43
|
)
|
||
Other income (expense), net
|
$
|
(103
|
)
|
|
$
|
(8
|
)
|
|
2016
|
|
2015
|
|
% Change
2015-2016
|
|||||
Total Revenues
|
|
|
|
|
|
|||||
Managed Care
|
$
|
38,382
|
|
|
$
|
20,966
|
|
|
83
|
%
|
Specialty Services
|
8,377
|
|
|
6,757
|
|
|
24
|
%
|
||
Eliminations
|
(6,152
|
)
|
|
(4,963
|
)
|
|
(24
|
)%
|
||
Consolidated Total
|
$
|
40,607
|
|
|
$
|
22,760
|
|
|
78
|
%
|
Earnings from Operations
|
|
|
|
|
|
|
|
|||
Managed Care
|
$
|
1,077
|
|
|
$
|
531
|
|
|
103
|
%
|
Specialty Services
|
183
|
|
|
174
|
|
|
5
|
%
|
||
Consolidated Total
|
$
|
1,260
|
|
|
$
|
705
|
|
|
79
|
%
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net cash provided by operating activities
|
$
|
1,489
|
|
|
$
|
1,851
|
|
|
$
|
658
|
|
Net cash used in investing activities
|
(1,265
|
)
|
|
(2,397
|
)
|
|
(813
|
)
|
|||
Net cash (used in) provided by financing activities
|
(82
|
)
|
|
2,717
|
|
|
305
|
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
—
|
|
|
(1
|
)
|
|
—
|
|
|||
Net increase in cash and cash equivalents
|
$
|
142
|
|
|
$
|
2,170
|
|
|
$
|
150
|
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
(Increase) decrease in premium and trade receivables
|
$
|
(50
|
)
|
|
$
|
74
|
|
|
$
|
(360
|
)
|
Increase (decrease) in unearned revenue
|
19
|
|
|
43
|
|
|
(27
|
)
|
|||
Net increase (decrease) in operating cash flow
|
$
|
(31
|
)
|
|
$
|
117
|
|
|
$
|
(387
|
)
|
|
Payments Due by Period
|
||||||||||||||||||
|
Total
|
|
Less Than
1 Year
|
|
1-3
Years
|
|
3-5
Years
|
|
More Than
5 Years
|
||||||||||
Medical claims liability
|
$
|
4,286
|
|
|
$
|
4,286
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Debt and interest
|
6,217
|
|
|
276
|
|
|
564
|
|
|
2,962
|
|
|
2,415
|
|
|||||
Operating lease obligations
|
793
|
|
|
169
|
|
|
287
|
|
|
182
|
|
|
155
|
|
|||||
Purchase obligations
|
246
|
|
|
148
|
|
|
49
|
|
|
33
|
|
|
16
|
|
|||||
Other long-term liabilities
(1)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
$
|
11,542
|
|
|
$
|
4,879
|
|
|
$
|
900
|
|
|
$
|
3,177
|
|
|
$
|
2,586
|
|
•
|
invest an additional
$30 million
through the California Organized Investment Network over the
five
years following completion of the acquisition;
|
•
|
build a service center in an economically distressed community in California, investing
$200 million
over
10
years and employing at least
300
people;
|
•
|
contribute
$65 million
to improve enrollee health outcomes (
$10 million
over
five
years), support locally-based consumer assistance programs (
$5 million
over
five
years) and strengthen the healthcare delivery system (
$50 million
over
five
years), of which the present value of
$61 million
was expensed in the year ended December 31, 2016 and classified as SG&A expenses in the Consolidated Statements of Operations; and
|
•
|
invest
$75 million
of its investment portfolio in vehicles supporting California’s healthcare infrastructure.
|
Intangible Asset
|
|
Amortization Period
|
Purchased contract rights
|
|
5 - 15 years
|
Provider contracts
|
|
4 - 15 years
|
Customer relationships
|
|
3 - 15 years
|
Trade names
|
|
7 - 20 years
|
Developed technologies
|
|
5 years
|
•
|
Appropriate leveling of care for neonatal intensive care unit hospital admissions, other inpatient hospital admissions, and observation admissions, in accordance with Interqual or other criteria.
|
•
|
Management of our pre-authorization list and more stringent review of durable medical equipment and injectibles.
|
•
|
Emergency room program designed to collaboratively work with hospitals to steer non-emergency care away from the costly emergency room setting (through patient education, on-site alternative urgent care settings, etc.).
|
•
|
Increased emphasis on case management and clinical rounding where case managers are nurses or social workers who are employed by the health plan to assist selected patients with the coordination of healthcare services in order to meet a patient's specific healthcare needs.
|
•
|
Incorporation of disease management which is a comprehensive, multidisciplinary, collaborative approach to chronic illnesses such as asthma.
|
•
|
Prenatal and infant health programs utilized in our
Start Smart For Your Baby
outreach service.
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
4,072
|
|
|
$
|
3,930
|
|
Premium and trade receivables
|
3,413
|
|
|
3,215
|
|
||
Short-term investments
|
531
|
|
|
505
|
|
||
Other current assets
|
687
|
|
|
715
|
|
||
Total current assets
|
8,703
|
|
|
8,365
|
|
||
Long-term investments
|
5,312
|
|
|
4,545
|
|
||
Restricted deposits
|
135
|
|
|
138
|
|
||
Property, software and equipment, net
|
1,104
|
|
|
797
|
|
||
Goodwill
|
4,749
|
|
|
4,712
|
|
||
Intangible assets, net
|
1,398
|
|
|
1,545
|
|
||
Other long-term assets
|
454
|
|
|
95
|
|
||
Total assets
|
$
|
21,855
|
|
|
$
|
20,197
|
|
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Medical claims liability
|
$
|
4,286
|
|
|
$
|
3,929
|
|
Accounts payable and accrued expenses
|
4,165
|
|
|
3,763
|
|
||
Return of premium payable
|
549
|
|
|
614
|
|
||
Unearned revenue
|
328
|
|
|
313
|
|
||
Current portion of long-term debt
|
4
|
|
|
4
|
|
||
Total current liabilities
|
9,332
|
|
|
8,623
|
|
||
Long-term debt
|
4,695
|
|
|
4,651
|
|
||
Other long-term liabilities
|
952
|
|
|
869
|
|
||
Total liabilities
|
14,979
|
|
|
14,143
|
|
||
Commitments and contingencies
|
|
|
|
|
|
||
Redeemable noncontrolling interests
|
12
|
|
|
145
|
|
||
Stockholders’ equity:
|
|
|
|
|
|
||
Preferred stock, $.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2017 and December 31, 2016
|
—
|
|
|
—
|
|
||
Common stock, $.001 par value; authorized 400,000 shares; 180,379 issued and 173,437 outstanding at December 31, 2017, and 178,134 issued and 171,919 outstanding at December 31, 2016
|
—
|
|
|
—
|
|
||
Additional paid-in capital
|
4,349
|
|
|
4,190
|
|
||
Accumulated other comprehensive loss
|
(3
|
)
|
|
(36
|
)
|
||
Retained earnings
|
2,748
|
|
|
1,920
|
|
||
Treasury stock, at cost (6,942 and 6,215 shares, respectively)
|
(244
|
)
|
|
(179
|
)
|
||
Total Centene stockholders’ equity
|
6,850
|
|
|
5,895
|
|
||
Noncontrolling interest
|
14
|
|
|
14
|
|
||
Total stockholders’ equity
|
6,864
|
|
|
5,909
|
|
||
Total liabilities, redeemable noncontrolling interests and stockholders’ equity
|
$
|
21,855
|
|
|
$
|
20,197
|
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net earnings
|
$
|
808
|
|
|
$
|
561
|
|
|
$
|
357
|
|
Reclassification adjustment, net of tax
|
(2
|
)
|
|
(2
|
)
|
|
—
|
|
|||
Change in unrealized gain (loss) on investments, net of tax
|
28
|
|
|
(22
|
)
|
|
(4
|
)
|
|||
Defined benefit pension plan net gain arising during the period, net of tax
|
1
|
|
|
1
|
|
|
—
|
|
|||
Foreign currency translation adjustments
|
6
|
|
|
(3
|
)
|
|
(5
|
)
|
|||
Other comprehensive earnings (loss)
|
33
|
|
|
(26
|
)
|
|
(9
|
)
|
|||
Comprehensive earnings
|
841
|
|
|
535
|
|
|
348
|
|
|||
Comprehensive (earnings) loss attributable to the noncontrolling interests
|
20
|
|
|
1
|
|
|
(2
|
)
|
|||
Comprehensive earnings attributable to Centene Corporation
|
$
|
861
|
|
|
$
|
536
|
|
|
$
|
346
|
|
|
Centene Stockholders’ Equity
|
|
|
|
|
||||||||||||||||||||||||||||
|
Common Stock
|
|
|
|
|
|
|
|
Treasury Stock
|
|
|
|
|
||||||||||||||||||||
|
$.001 Par
Value
Shares
|
|
Amt
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Retained
Earnings
|
|
$.001 Par
Value
Shares
|
|
Amt
|
|
Non
controlling
Interest
|
|
Total
|
||||||||||||||||
Balance, December 31, 2014
|
124,275
|
|
|
$
|
—
|
|
|
$
|
840
|
|
|
$
|
(1
|
)
|
|
$
|
1,003
|
|
|
5,841
|
|
|
$
|
(98
|
)
|
|
$
|
(1
|
)
|
|
$
|
1,743
|
|
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
355
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
355
|
|
|||||||
Other comprehensive earnings (loss), net of ($3) tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
|||||||
Common stock issued for acquisitions
|
—
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
—
|
|
|
(248
|
)
|
|
4
|
|
|
—
|
|
|
12
|
|
|||||||
Common stock issued for employee benefit plans
|
2,580
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|||||||
Common stock repurchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
919
|
|
|
(53
|
)
|
|
—
|
|
|
(53
|
)
|
|||||||
Stock compensation expense
|
—
|
|
|
—
|
|
|
71
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
71
|
|
|||||||
Excess tax benefits from stock compensation
|
—
|
|
|
—
|
|
|
25
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
25
|
|
|||||||
Contribution from noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
11
|
|
|||||||
Reclassification to redeemable noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
1
|
|
|||||||
Balance, December 31, 2015
|
126,855
|
|
|
$
|
—
|
|
|
$
|
956
|
|
|
$
|
(10
|
)
|
|
$
|
1,358
|
|
|
6,512
|
|
|
$
|
(147
|
)
|
|
$
|
11
|
|
|
$
|
2,168
|
|
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
562
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
563
|
|
|||||||
Other comprehensive earnings (loss), net of ($14) tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(26
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(26
|
)
|
|||||||
Common stock issued for acquisitions
|
48,218
|
|
|
—
|
|
|
3,074
|
|
|
—
|
|
|
—
|
|
|
(1,375
|
)
|
|
31
|
|
|
—
|
|
|
3,105
|
|
|||||||
Common stock issued for employee benefit plans
|
3,061
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|||||||
Common stock repurchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,078
|
|
|
(63
|
)
|
|
—
|
|
|
(63
|
)
|
|||||||
Stock compensation expense
|
—
|
|
|
—
|
|
|
148
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
148
|
|
|||||||
Contribution from noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
2
|
|
|||||||
Balance, December 31, 2016
|
178,134
|
|
|
$
|
—
|
|
|
$
|
4,190
|
|
|
$
|
(36
|
)
|
|
$
|
1,920
|
|
|
6,215
|
|
|
$
|
(179
|
)
|
|
$
|
14
|
|
|
$
|
5,909
|
|
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
828
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
828
|
|
|||||||
Other comprehensive earnings, net of $15 tax
|
—
|
|
|
—
|
|
|
—
|
|
|
33
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33
|
|
|||||||
Common stock issued for employee benefit plans
|
2,245
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|||||||
Common stock repurchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
727
|
|
|
(65
|
)
|
|
—
|
|
|
(65
|
)
|
|||||||
Stock compensation expense
|
—
|
|
|
—
|
|
|
135
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
135
|
|
|||||||
Purchase of noncontrolling interest
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13
|
|
|||||||
Balance, December 31, 2017
|
180,379
|
|
|
$
|
—
|
|
|
$
|
4,349
|
|
|
$
|
(3
|
)
|
|
$
|
2,748
|
|
|
6,942
|
|
|
$
|
(244
|
)
|
|
$
|
14
|
|
|
$
|
6,864
|
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
||||||
Net earnings
|
$
|
808
|
|
|
$
|
561
|
|
|
$
|
357
|
|
Adjustments to reconcile net earnings to net cash provided by operating activities
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization
|
361
|
|
|
278
|
|
|
111
|
|
|||
Stock compensation expense
|
135
|
|
|
148
|
|
|
71
|
|
|||
Debt extinguishment costs
|
—
|
|
|
(7
|
)
|
|
—
|
|
|||
Deferred income taxes
|
(108
|
)
|
|
92
|
|
|
(17
|
)
|
|||
Gain on contingent consideration
|
(1
|
)
|
|
(5
|
)
|
|
(44
|
)
|
|||
Goodwill and intangible adjustment
|
—
|
|
|
—
|
|
|
38
|
|
|||
Changes in assets and liabilities
|
|
|
|
|
|
|
|
|
|||
Premium and trade receivables
|
(50
|
)
|
|
74
|
|
|
(360
|
)
|
|||
Other assets
|
(146
|
)
|
|
167
|
|
|
(102
|
)
|
|||
Medical claims liabilities
|
359
|
|
|
145
|
|
|
536
|
|
|||
Unearned revenue
|
19
|
|
|
43
|
|
|
(27
|
)
|
|||
Accounts payable and accrued expenses
|
53
|
|
|
402
|
|
|
39
|
|
|||
Other long-term liabilities
|
68
|
|
|
(61
|
)
|
|
51
|
|
|||
Other operating activities, net
|
(9
|
)
|
|
14
|
|
|
5
|
|
|||
Net cash provided by operating activities
|
1,489
|
|
|
1,851
|
|
|
658
|
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|||
Capital expenditures
|
(422
|
)
|
|
(306
|
)
|
|
(150
|
)
|
|||
Purchases of investments
|
(2,704
|
)
|
|
(2,450
|
)
|
|
(1,321
|
)
|
|||
Sales and maturities of investments
|
1,899
|
|
|
1,656
|
|
|
669
|
|
|||
Investments in acquisitions, net of cash acquired
|
(50
|
)
|
|
(1,297
|
)
|
|
(18
|
)
|
|||
Other investing activities, net
|
12
|
|
|
—
|
|
|
7
|
|
|||
Net cash used in investing activities
|
(1,265
|
)
|
|
(2,397
|
)
|
|
(813
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|||
Proceeds from borrowings
|
1,400
|
|
|
8,946
|
|
|
1,925
|
|
|||
Payment of long-term debt
|
(1,353
|
)
|
|
(6,076
|
)
|
|
(1,583
|
)
|
|||
Common stock repurchases
|
(65
|
)
|
|
(63
|
)
|
|
(53
|
)
|
|||
Purchase of noncontrolling interest
|
(66
|
)
|
|
(14
|
)
|
|
—
|
|
|||
Debt issuance costs
|
(3
|
)
|
|
(76
|
)
|
|
(4
|
)
|
|||
Other financing activities, net
|
5
|
|
|
—
|
|
|
20
|
|
|||
Net cash (used in) provided by financing activities
|
(82
|
)
|
|
2,717
|
|
|
305
|
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
—
|
|
|
(1
|
)
|
|
—
|
|
|||
Net increase in cash and cash equivalents
|
142
|
|
|
2,170
|
|
|
150
|
|
|||
Cash and cash equivalents,
beginning of period
|
3,930
|
|
|
1,760
|
|
|
1,610
|
|
|||
Cash and cash equivalents,
end of period
|
$
|
4,072
|
|
|
$
|
3,930
|
|
|
$
|
1,760
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
||||
Interest paid
|
$
|
237
|
|
|
$
|
165
|
|
|
$
|
55
|
|
Income taxes paid
|
$
|
496
|
|
|
$
|
556
|
|
|
$
|
328
|
|
Equity issued in connection with acquisitions
|
$
|
—
|
|
|
$
|
3,105
|
|
|
$
|
12
|
|
•
|
Available for sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.
|
•
|
Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.
|
•
|
Variable rate debt: The carrying amount of our floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.
|
•
|
Interest rate swap: Estimated based on third-party market prices based on the forward 3-month LIBOR curve.
|
•
|
Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.
|
Fixed Asset
|
|
Depreciation Period
|
Buildings and land improvements
|
|
5 - 40 years
|
Computer hardware and software
|
|
2 - 7 years
|
Furniture and equipment
|
|
3 - 10 years
|
Land improvements
|
|
3 - 20 years
|
Leasehold improvements
|
|
1 - 20 years
|
Intangible Asset
|
|
Amortization Period
|
Purchased contract rights
|
|
5 - 15 years
|
Provider contracts
|
|
4 - 15 years
|
Customer relationships
|
|
3 - 15 years
|
Trade names
|
|
7 - 20 years
|
Developed technologies
|
|
5 years
|
|
2017
|
|
2016
|
|
2015
|
||||||
Allowances, beginning of year
|
$
|
29
|
|
|
$
|
10
|
|
|
$
|
5
|
|
Amounts charged to expense
|
35
|
|
|
33
|
|
|
12
|
|
|||
Write-offs of uncollectible receivables
|
(40
|
)
|
|
(14
|
)
|
|
(7
|
)
|
|||
Allowances, end of year
|
$
|
24
|
|
|
$
|
29
|
|
|
$
|
10
|
|
Assets Acquired and Liabilities Assumed
|
|
|
||
Cash and cash equivalents
|
|
$
|
956
|
|
Premium and trade receivables
(a)
|
|
1,890
|
|
|
Short-term investments
|
|
74
|
|
|
Other current assets
|
|
524
|
|
|
Long-term investments
|
|
2,037
|
|
|
Restricted deposits
|
|
30
|
|
|
Property, software and equipment, net
|
|
41
|
|
|
Intangible assets
(b)
|
|
1,530
|
|
|
Other long-term assets
|
|
136
|
|
|
Total assets acquired
|
|
7,218
|
|
|
|
|
|
||
Medical claims liability
(c)
|
|
1,482
|
|
|
Borrowings under revolving credit facility
|
|
285
|
|
|
Accounts payable and accrued expenses
(c) (d)
|
|
2,297
|
|
|
Return of premium payable
|
|
435
|
|
|
Unearned revenue
|
|
130
|
|
|
Long-term deferred tax liabilities
(e)
|
|
311
|
|
|
Long-term debt
(f)
|
|
418
|
|
|
Other long-term liabilities
|
|
432
|
|
|
Total liabilities assumed
|
|
5,790
|
|
|
|
|
|
||
Total identifiable net assets
|
|
1,428
|
|
|
Goodwill
(g)
|
|
3,859
|
|
|
Total assets acquired and liabilities assumed
|
|
$
|
5,287
|
|
(a)
|
The fair value of premium and trade receivables approximated their historical cost, with the exception of the risk corridor receivable associated with the Health Insurance Marketplace. The fair value of the risk corridor receivable was estimated at
$9 million
.
|
(b)
|
The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets is determined primarily using variations of the "income approach," which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, were also utilized in estimating the fair value of certain intangible assets. The Company determined the fair value of intangibles to be
$1,530 million
with a weighted average life of
12
years. Intangible assets include purchased contract rights, provider contracts, trade names and developed technologies.
|
(c)
|
Medical claims liability and accounts payable and accrued expenses include
$160 million
of reserves associated with substance abuse rehabilitation claims primarily related to periods prior to the acquisition date.
|
(d)
|
Accounts payable and accrued expenses include approximately
$253 million
related to premium deficiency reserves based on cost trends existing prior to the acquisition date. The premium deficiency reserves are primarily associated with losses in the individual commercial business, largely in California, unfavorable performance in the Arizona commercial business as well as unfavorable performance in the Medicare business primarily in Oregon and Arizona.
|
(e)
|
The deferred tax liabilities are presented net of
$365 million
of deferred tax assets.
|
(f)
|
Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Health Net's
$400 million
Senior Notes assumed in the acquisition was
$418 million
. The
$18 million
increase was initially being amortized as a reduction to interest expense over the remaining life of the debt; however, in November 2016, this debt was redeemed. See further discussion in Note
11
,
Debt.
|
(g)
|
The acquisition resulted in
$3,859 million
of goodwill related primarily to buyer specific synergies expected from the acquisition and the assembled workforce of Health Net. This goodwill is not deductible for income tax purposes. The Company assigned
$3,643 million
of goodwill to the Managed Care segment and
$216 million
of goodwill to the Specialty Services segment.
|
|
|
Fair Value
|
|
Weighted Average Useful Life (in years)
|
||
Purchased contract rights
|
|
$
|
1,095
|
|
|
13
|
Provider contracts
|
|
181
|
|
|
11
|
|
Trade names
|
|
150
|
|
|
10
|
|
Developed technologies
|
|
104
|
|
|
5
|
|
Total intangible assets acquired
|
|
$
|
1,530
|
|
|
12
|
|
|
December 31, 2015
|
||
Total revenues
|
|
$
|
38,826
|
|
Net earnings attributable to Centene Corporation
|
|
$
|
245
|
|
Diluted earnings per share
|
|
$
|
1.43
|
|
•
|
additional interest income associated with adjusting the amortized cost of Health Net's investment portfolio to fair value;
|
•
|
elimination of historical Health Net intangible asset amortization expense and addition of amortization expense based on the current values of identifiable intangible assets;
|
•
|
adjustments to premium revenues related to the risk corridor receivables associated with the Health Insurance Marketplace to align with Centene's accounting policies;
|
•
|
interest expense associated with financing the acquisition and amortization of the fair value adjustment to Health Net's debt;
|
•
|
additional stock compensation expense related to the amortization of the fair value increase to Health Net rollover stock awards.
|
•
|
increased tax expense due to the assumption that Centene would be subject to the IRS Regulation 162(m)(6) beginning in 2015; and
|
•
|
elimination of acquisition related costs.
|
|
|
Employee Termination Costs
|
|
Stock Based Compensation
|
|
Total
|
||||||
Total accrued restructuring costs as of December 31, 2015
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Charges incurred
|
|
46
|
|
|
43
|
|
|
89
|
|
|||
Paid/settled
|
|
(28
|
)
|
|
(43
|
)
|
|
(71
|
)
|
|||
Total accrued restructuring costs as of December 31, 2016
|
|
$
|
18
|
|
|
$
|
—
|
|
|
$
|
18
|
|
Charges incurred
|
|
4
|
|
|
3
|
|
|
7
|
|
|||
Paid/Settled
|
|
(20
|
)
|
|
$
|
(3
|
)
|
|
(23
|
)
|
||
Total accrued restructuring costs as of December 31, 2017
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2
|
|
•
|
invest an additional
$30 million
through the California Organized Investment Network over the
five
years following completion of the acquisition;
|
•
|
build a service center in an economically distressed community in California, investing
$200 million
over
10
years and employing at least
300
people;
|
•
|
contribute
$65 million
to improve enrollee health outcomes (
$10 million
over
five
years), support locally based consumer assistance programs (
$5 million
over
five
years) and strengthen the healthcare delivery system (
$50 million
over
five
years), of which the present value of
$61 million
was expensed in the
year ended December 31, 2016
, and classified as SG&A expenses in the Consolidated Statements of Operations; and
|
•
|
invest
$75 million
of its investment portfolio in vehicles supporting California’s healthcare infrastructure.
|
|
|
2017
|
|
2016
|
|
2015
|
|||
Arkansas Total Care
|
|
74
|
%
|
|
—
|
%
|
|
—
|
%
|
Celtic Insurance Company
|
|
100
|
%
|
|
100
|
%
|
|
75
|
%
|
Cenpatico Integrated Care
|
|
80
|
%
|
|
80
|
%
|
|
80
|
%
|
Centurion
|
|
51
|
%
|
|
51
|
%
|
|
51
|
%
|
Foundation Care
(1)
|
|
80
|
%
|
|
—
|
%
|
|
—
|
%
|
Home State Health Plan
|
|
95
|
%
|
|
95
|
%
|
|
95
|
%
|
The Practice (Group) Limited (TPG)
(2)
|
|
75
|
%
|
|
75
|
%
|
|
49
|
%
|
U.S. Medical Management
(3)
|
|
100
|
%
|
|
68
|
%
|
|
68
|
%
|
Balance, December 31, 2016
|
$
|
145
|
|
Noncontrolling interest purchased related to USMM
|
(115
|
)
|
|
Contribution from noncontrolling interest
|
2
|
|
|
Net losses attributable to noncontrolling interests
|
(20
|
)
|
|
Balance, December 31, 2017
|
$
|
12
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized Losses
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized Losses
|
|
Fair
Value
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
$
|
311
|
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
309
|
|
|
$
|
364
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
363
|
|
Corporate securities
|
2,208
|
|
|
12
|
|
|
(10
|
)
|
|
2,210
|
|
|
1,933
|
|
|
12
|
|
|
(13
|
)
|
|
1,932
|
|
||||||||
Restricted certificates of deposit
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|
5
|
|
||||||||
Restricted cash equivalents
|
17
|
|
|
—
|
|
|
—
|
|
|
17
|
|
|
6
|
|
|
—
|
|
|
—
|
|
|
6
|
|
||||||||
Municipal securities
|
2,085
|
|
|
12
|
|
|
(10
|
)
|
|
2,087
|
|
|
1,767
|
|
|
1
|
|
|
(35
|
)
|
|
1,733
|
|
||||||||
Asset-backed securities
|
437
|
|
|
1
|
|
|
(1
|
)
|
|
437
|
|
|
317
|
|
|
1
|
|
|
(1
|
)
|
|
317
|
|
||||||||
Residential mortgage-backed securities
|
337
|
|
|
1
|
|
|
(6
|
)
|
|
332
|
|
|
219
|
|
|
1
|
|
|
(5
|
)
|
|
215
|
|
||||||||
Commercial mortgage- backed securities
|
272
|
|
|
1
|
|
|
(2
|
)
|
|
271
|
|
|
343
|
|
|
—
|
|
|
(5
|
)
|
|
338
|
|
||||||||
Equity method investments
|
176
|
|
|
—
|
|
|
—
|
|
|
176
|
|
|
163
|
|
|
—
|
|
|
—
|
|
|
163
|
|
||||||||
Life insurance contracts
|
135
|
|
|
—
|
|
|
—
|
|
|
135
|
|
|
116
|
|
|
—
|
|
|
—
|
|
|
116
|
|
||||||||
Total
|
$
|
5,982
|
|
|
$
|
27
|
|
|
$
|
(31
|
)
|
|
$
|
5,978
|
|
|
$
|
5,233
|
|
|
$
|
15
|
|
|
$
|
(60
|
)
|
|
$
|
5,188
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
|
Less Than 12 Months
|
|
12 Months or More
|
|
Less Than 12 Months
|
|
12 Months or More
|
||||||||||||||||||||||||
|
Unrealized Losses
|
|
Fair
Value
|
|
Unrealized Losses
|
|
Fair
Value
|
|
Unrealized Losses
|
|
Fair
Value
|
|
Unrealized Losses
|
|
Fair
Value
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
$
|
(1
|
)
|
|
$
|
222
|
|
|
$
|
(1
|
)
|
|
$
|
79
|
|
|
$
|
(1
|
)
|
|
$
|
215
|
|
|
$
|
—
|
|
|
$
|
2
|
|
Corporate securities
|
(6
|
)
|
|
1,044
|
|
|
(4
|
)
|
|
185
|
|
|
(12
|
)
|
|
1,020
|
|
|
(1
|
)
|
|
39
|
|
||||||||
Municipal securities
|
(7
|
)
|
|
943
|
|
|
(3
|
)
|
|
175
|
|
|
(35
|
)
|
|
1,423
|
|
|
—
|
|
|
30
|
|
||||||||
Asset-backed securities
|
(1
|
)
|
|
228
|
|
|
—
|
|
|
28
|
|
|
(1
|
)
|
|
101
|
|
|
—
|
|
|
18
|
|
||||||||
Residential mortgage- backed securities
|
(1
|
)
|
|
109
|
|
|
(5
|
)
|
|
171
|
|
|
(5
|
)
|
|
188
|
|
|
—
|
|
|
—
|
|
||||||||
Commercial mortgage- backed securities
|
(1
|
)
|
|
112
|
|
|
(1
|
)
|
|
51
|
|
|
(5
|
)
|
|
271
|
|
|
—
|
|
|
—
|
|
||||||||
Total
|
$
|
(17
|
)
|
|
$
|
2,658
|
|
|
$
|
(14
|
)
|
|
$
|
689
|
|
|
$
|
(59
|
)
|
|
$
|
3,218
|
|
|
$
|
(1
|
)
|
|
$
|
89
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||||||||||
|
Investments
|
|
Restricted Deposits
|
|
Investments
|
|
Restricted Deposits
|
||||||||||||||||||||||||
|
Amortized
Cost
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Fair
Value
|
||||||||||||||||
One year or less
|
$
|
474
|
|
|
$
|
474
|
|
|
$
|
48
|
|
|
$
|
47
|
|
|
$
|
500
|
|
|
$
|
500
|
|
|
$
|
91
|
|
|
$
|
91
|
|
One year through five years
|
2,424
|
|
|
2,420
|
|
|
88
|
|
|
88
|
|
|
1,982
|
|
|
1,974
|
|
|
47
|
|
|
47
|
|
||||||||
Five years through ten years
|
1,773
|
|
|
1,779
|
|
|
—
|
|
|
—
|
|
|
1,101
|
|
|
1,089
|
|
|
—
|
|
|
—
|
|
||||||||
Greater than ten years
|
129
|
|
|
130
|
|
|
—
|
|
|
—
|
|
|
633
|
|
|
617
|
|
|
—
|
|
|
—
|
|
||||||||
Asset-backed securities
|
1,046
|
|
|
1,040
|
|
|
—
|
|
|
—
|
|
|
879
|
|
|
870
|
|
|
—
|
|
|
—
|
|
||||||||
Total
|
$
|
5,846
|
|
|
$
|
5,843
|
|
|
$
|
136
|
|
|
$
|
135
|
|
|
$
|
5,095
|
|
|
$
|
5,050
|
|
|
$
|
138
|
|
|
$
|
138
|
|
Level Input:
|
|
Input Definition:
|
Level I
|
|
Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
|
|
|
|
Level II
|
|
Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
|
|
|
|
Level III
|
|
Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents
|
$
|
4,072
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,072
|
|
Investments available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
$
|
195
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
195
|
|
Corporate securities
|
—
|
|
|
2,210
|
|
|
—
|
|
|
2,210
|
|
||||
Municipal securities
|
—
|
|
|
2,087
|
|
|
—
|
|
|
2,087
|
|
||||
Asset-backed securities
|
—
|
|
|
437
|
|
|
—
|
|
|
437
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
332
|
|
|
—
|
|
|
332
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
271
|
|
|
—
|
|
|
271
|
|
||||
Total investments
|
$
|
195
|
|
|
$
|
5,337
|
|
|
$
|
—
|
|
|
$
|
5,532
|
|
Restricted deposits available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash and cash equivalents
|
$
|
17
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
17
|
|
Certificates of deposit
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
114
|
|
|
—
|
|
|
—
|
|
|
114
|
|
||||
Total restricted deposits
|
$
|
135
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
135
|
|
Other long-term assets:
|
|
|
|
|
|
|
|
||||||||
Interest rate swap agreements
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
1
|
|
Total assets at fair value
|
$
|
4,402
|
|
|
$
|
5,338
|
|
|
$
|
—
|
|
|
$
|
9,740
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities
|
|
|
|
|
|
|
|
||||||||
Other long-term liabilities:
|
|
|
|
|
|
|
|
||||||||
Interest rate swap agreements
|
$
|
—
|
|
|
$
|
72
|
|
|
$
|
—
|
|
|
$
|
72
|
|
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
72
|
|
|
$
|
—
|
|
|
$
|
72
|
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents
|
$
|
3,930
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,930
|
|
Investments available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
$
|
221
|
|
|
$
|
15
|
|
|
$
|
—
|
|
|
$
|
236
|
|
Corporate securities
|
—
|
|
|
1,932
|
|
|
—
|
|
|
1,932
|
|
||||
Municipal securities
|
—
|
|
|
1,733
|
|
|
—
|
|
|
1,733
|
|
||||
Asset-backed securities
|
—
|
|
|
317
|
|
|
—
|
|
|
317
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
215
|
|
|
—
|
|
|
215
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
338
|
|
|
—
|
|
|
338
|
|
||||
Total investments
|
$
|
221
|
|
|
$
|
4,550
|
|
|
$
|
—
|
|
|
$
|
4,771
|
|
Restricted deposits available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash and cash equivalents
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6
|
|
Certificates of deposit
|
5
|
|
|
—
|
|
|
—
|
|
|
5
|
|
||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies
|
127
|
|
|
—
|
|
|
—
|
|
|
127
|
|
||||
Total restricted deposits
|
$
|
138
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
138
|
|
Other long-term assets:
|
|
|
|
|
|
|
|
||||||||
Interest rate swap agreements
|
$
|
—
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
4
|
|
Total assets at fair value
|
$
|
4,289
|
|
|
$
|
4,554
|
|
|
$
|
—
|
|
|
$
|
8,843
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities
|
|
|
|
|
|
|
|
||||||||
Other long-term liabilities:
|
|
|
|
|
|
|
|
||||||||
Interest rate swap agreements
|
$
|
—
|
|
|
$
|
62
|
|
|
$
|
—
|
|
|
$
|
62
|
|
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
62
|
|
|
$
|
—
|
|
|
$
|
62
|
|
|
2017
|
|
2016
|
||||
Land
|
$
|
130
|
|
|
$
|
113
|
|
Building
|
367
|
|
|
271
|
|
||
Computer software
|
542
|
|
|
377
|
|
||
Computer hardware
|
248
|
|
|
179
|
|
||
Furniture and office equipment
|
186
|
|
|
126
|
|
||
Leasehold improvements
|
221
|
|
|
173
|
|
||
|
1,694
|
|
|
1,239
|
|
||
Less accumulated depreciation
|
(590
|
)
|
|
(442
|
)
|
||
Property, software and equipment, net
|
$
|
1,104
|
|
|
$
|
797
|
|
|
Managed Care
|
|
Specialty Services
|
|
Total
|
||||||
Balance as of December 31, 2015
|
$
|
361
|
|
|
$
|
481
|
|
|
$
|
842
|
|
Acquisitions and purchase accounting adjustments
|
3,657
|
|
|
216
|
|
|
3,873
|
|
|||
Translation impact
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|||
Balance as of December 31, 2016
|
4,015
|
|
|
697
|
|
|
4,712
|
|
|||
Acquisitions and purchase accounting adjustments
|
—
|
|
|
37
|
|
|
37
|
|
|||
Balance as of December 31, 2017
|
$
|
4,015
|
|
|
$
|
734
|
|
|
$
|
4,749
|
|
|
|
|
|
|
Weighted Average Life in Years
|
|||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|||||
Purchased contract rights
|
$
|
1,173
|
|
|
$
|
1,171
|
|
|
12.6
|
|
12.6
|
|
Provider contracts
|
274
|
|
|
285
|
|
|
11.9
|
|
10.7
|
|
||
Customer relationships
|
22
|
|
|
22
|
|
|
8.2
|
|
8.2
|
|
||
Trade names
|
162
|
|
|
163
|
|
|
9.6
|
|
9.6
|
|
||
Developed technologies
|
109
|
|
|
110
|
|
|
5.0
|
|
5.0
|
|
||
Other Intangibles
|
7
|
|
|
—
|
|
|
2.8
|
|
—
|
|
||
Intangible assets
|
1,747
|
|
|
1,751
|
|
|
11.6
|
|
11.5
|
|
||
Less accumulated amortization:
|
|
|
|
|
|
|
|
|||||
Purchased contract rights
|
(188
|
)
|
|
(95
|
)
|
|
|
|
|
|||
Provider contracts
|
(66
|
)
|
|
(55
|
)
|
|
|
|
|
|||
Customer relationships
|
(21
|
)
|
|
(21
|
)
|
|
|
|
|
|||
Trade names
|
(34
|
)
|
|
(17
|
)
|
|
|
|
|
|||
Developed technologies
|
(40
|
)
|
|
(18
|
)
|
|
|
|
|
|||
Total accumulated amortization
|
(349
|
)
|
|
(206
|
)
|
|
|
|
|
|||
Intangible assets, net
|
$
|
1,398
|
|
|
$
|
1,545
|
|
|
|
|
|
Year
|
|
Expense
|
||
2018
|
|
$
|
156
|
|
2019
|
|
156
|
|
|
2020
|
|
154
|
|
|
2021
|
|
134
|
|
|
2022
|
|
128
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Balance, January 1
|
|
$
|
3,929
|
|
|
$
|
2,298
|
|
|
$
|
1,723
|
|
Less: reinsurance recoverable
|
|
5
|
|
|
—
|
|
|
—
|
|
|||
Balance, January 1, net
|
|
3,924
|
|
|
2,298
|
|
|
1,723
|
|
|||
Acquisitions
|
|
—
|
|
|
1,482
|
|
|
79
|
|
|||
Incurred related to:
|
|
|
|
|
|
|
||||||
Current year
|
|
38,225
|
|
|
30,946
|
|
|
17,471
|
|
|||
Prior years
|
|
(374
|
)
|
|
(310
|
)
|
|
(229
|
)
|
|||
Total incurred
|
|
37,851
|
|
|
30,636
|
|
|
17,242
|
|
|||
Paid related to:
|
|
|
|
|
|
|
||||||
Current year
|
|
34,196
|
|
|
28,532
|
|
|
15,279
|
|
|||
Prior years
|
|
3,311
|
|
|
1,960
|
|
|
1,467
|
|
|||
Total paid
|
|
37,507
|
|
|
30,492
|
|
|
16,746
|
|
|||
Balance at December 31, net
|
|
4,268
|
|
|
3,924
|
|
|
2,298
|
|
|||
Reinsurance recoverable
|
|
18
|
|
|
5
|
|
|
—
|
|
|||
Balance, December 31
|
|
$
|
4,286
|
|
|
$
|
3,929
|
|
|
$
|
2,298
|
|
|
December 31, 2017
|
|||||||||
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
Total IBNR Plus Expected Development on Reported Claims
|
|
Cumulative Paid Claims
|
|||||
|
|
|
||||||||
|
|
|
|
|
|
|||||
2015
|
$
|
30,310
|
|
|
$
|
—
|
|
|
156.7
|
|
2016
|
34,296
|
|
|
48
|
|
|
179.1
|
|
||
2017
|
38,225
|
|
|
3,330
|
|
|
192.0
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
Risk adjustment
|
$
|
(677
|
)
|
|
$
|
(425
|
)
|
Reinsurance
|
15
|
|
|
122
|
|
||
Risk corridor
|
6
|
|
|
(3
|
)
|
||
Minimum MLR
|
(22
|
)
|
|
(18
|
)
|
||
Cost sharing reductions
|
(96
|
)
|
|
(147
|
)
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
$1,400 million 5.625% Senior notes, due February 15, 2021
|
$
|
1,400
|
|
|
$
|
1,400
|
|
$1,000 million 4.75% Senior notes, due May 15, 2022
|
1,006
|
|
|
1,008
|
|
||
$1,000 million 6.125% Senior notes, due February 15, 2024
|
1,000
|
|
|
1,000
|
|
||
$1,200 million 4.75% Senior notes, due January 15, 2025
|
1,200
|
|
|
1,200
|
|
||
Fair value of interest rate swap agreements
|
(71
|
)
|
|
(58
|
)
|
||
Total senior notes
|
4,535
|
|
|
4,550
|
|
||
Revolving credit agreement
|
150
|
|
|
100
|
|
||
Mortgage notes payable
|
61
|
|
|
64
|
|
||
Capital leases and other
|
18
|
|
|
18
|
|
||
Debt issuance costs
|
(65
|
)
|
|
(77
|
)
|
||
Total debt
|
4,699
|
|
|
4,655
|
|
||
Less current portion
|
(4
|
)
|
|
(4
|
)
|
||
Long-term debt
|
$
|
4,695
|
|
|
$
|
4,651
|
|
Expiration Date
|
|
Notional Amount
|
||
February 15, 2021
|
|
$
|
600
|
|
May 15, 2022
|
|
500
|
|
|
February 15, 2024
|
|
1,000
|
|
|
January 15, 2025
|
|
600
|
|
|
Total
|
|
$
|
2,700
|
|
2018
|
|
$
|
4
|
|
2019
|
|
16
|
|
|
2020
|
|
4
|
|
|
2021
|
|
1,451
|
|
|
2022
|
|
1,151
|
|
|
Thereafter
|
|
2,203
|
|
|
Total
|
|
$
|
4,829
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Current provision
|
|
|
|
|
|
||||||
Federal
|
$
|
421
|
|
|
$
|
485
|
|
|
$
|
332
|
|
State and local
|
14
|
|
|
22
|
|
|
26
|
|
|||
Total current provision
|
435
|
|
|
507
|
|
|
358
|
|
|||
Deferred provision
|
(109
|
)
|
|
92
|
|
|
(19
|
)
|
|||
Total income tax expense
|
$
|
326
|
|
|
$
|
599
|
|
|
$
|
339
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Earnings from continuing operations, before income tax expense
|
$
|
1,134
|
|
|
$
|
1,157
|
|
|
$
|
697
|
|
(Earnings) loss attributable to flow through noncontrolling interest
|
15
|
|
|
(8
|
)
|
|
1
|
|
|||
Earnings from continuing operations, less noncontrolling interest, before income tax expense
|
1,149
|
|
|
1,149
|
|
|
698
|
|
|||
|
|
|
|
|
|
|
|||||
Tax provision at the U.S. federal statutory rate
|
402
|
|
|
402
|
|
|
244
|
|
|||
State income taxes, net of federal income tax benefit
|
11
|
|
|
10
|
|
|
15
|
|
|||
Nondeductible compensation
|
58
|
|
|
23
|
|
|
2
|
|
|||
ACA Health Insurer Fee
|
—
|
|
|
162
|
|
|
75
|
|
|||
Income Tax Reform
|
(125
|
)
|
|
—
|
|
|
—
|
|
|||
Other, net
|
(20
|
)
|
|
2
|
|
|
3
|
|
|||
Income tax expense
|
$
|
326
|
|
|
$
|
599
|
|
|
$
|
339
|
|
|
2017
|
|
2016
|
||||
Deferred tax assets:
|
|
|
|
||||
Medical claims liability
|
$
|
46
|
|
|
$
|
66
|
|
Nondeductible liabilities
|
41
|
|
|
39
|
|
||
Net operating loss and tax credit carryforwards
|
94
|
|
|
101
|
|
||
Compensation accruals
|
129
|
|
|
156
|
|
||
Premium and trade receivables
|
45
|
|
|
79
|
|
||
Other
|
11
|
|
|
14
|
|
||
Deferred tax assets
|
366
|
|
|
455
|
|
||
Valuation allowance
|
(81
|
)
|
|
(86
|
)
|
||
Net deferred tax assets
|
$
|
285
|
|
|
$
|
369
|
|
|
|
|
|
||||
Deferred tax liabilities:
|
|
|
|
||||
Intangible assets
|
$
|
342
|
|
|
$
|
577
|
|
Prepaid assets
|
23
|
|
|
17
|
|
||
Fixed assets
|
84
|
|
|
65
|
|
||
Investments in joint ventures
|
20
|
|
|
11
|
|
||
Deferred revenue
|
26
|
|
|
—
|
|
||
Other
|
17
|
|
|
2
|
|
||
Deferred tax liabilities
|
512
|
|
|
672
|
|
||
Net deferred tax assets (liabilities)
|
$
|
(227
|
)
|
|
$
|
(303
|
)
|
|
Year Ended December 31,
|
||||||
|
2017
|
|
2016
|
||||
Gross unrecognized tax benefits, beginning of period
|
$
|
102
|
|
|
$
|
5
|
|
Gross increases:
|
|
|
|
||||
Current year tax positions
|
43
|
|
|
6
|
|
||
Prior year tax positions
|
113
|
|
|
93
|
|
||
Gross decreases:
|
|
|
|
||||
Prior year tax positions
|
—
|
|
|
(1
|
)
|
||
Statute of limitation lapses
|
(1
|
)
|
|
(1
|
)
|
||
Gross unrecognized tax benefits, end of period
|
$
|
257
|
|
|
$
|
102
|
|
|
Shares
|
|
Weighted Average Exercise Price
|
|
Aggregate Intrinsic Value
($ in millions)
|
|
Weighted Average Remaining Contractual Term
|
|||||
Outstanding as of December 31, 2016
|
320
|
|
|
$
|
17.44
|
|
|
|
|
|
||
Granted
|
1
|
|
|
68.60
|
|
|
|
|
|
|||
Exercised
|
(178
|
)
|
|
13.47
|
|
|
|
|
|
|||
Forfeited
|
(13
|
)
|
|
62.86
|
|
|
|
|
|
|||
Outstanding as of December 31, 2017
|
130
|
|
|
$
|
18.82
|
|
|
$
|
11
|
|
|
2.7
|
|
|
|
|
|
|
|
|
|||||
Exercisable as of December 31, 2017
|
115
|
|
|
$
|
13.75
|
|
|
$
|
10
|
|
|
1.9
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested balance as of December 31, 2016
|
4,790
|
|
|
$
|
55.75
|
|
Granted
|
1,412
|
|
|
95.13
|
|
|
Vested
|
(1,883
|
)
|
|
58.10
|
|
|
Forfeited
|
(150
|
)
|
|
20.40
|
|
|
Non-vested balance as of December 31, 2017
|
4,169
|
|
|
$
|
69.30
|
|
|
|
|
|
2018
|
$
|
146
|
|
2019
|
153
|
|
|
2020
|
138
|
|
|
2021
|
116
|
|
|
2022
|
73
|
|
|
Thereafter
|
167
|
|
|
|
$
|
793
|
|
•
|
periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments or the False Claims Act, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, and the Health Insurance Portability and Accountability Act of 1996;
|
•
|
litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions and medical malpractice, privacy, real estate, intellectual property and employment-related claims;
|
•
|
disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, and claims alleging that the Company has engaged in unfair business practices.
|
|
2017
|
|
2016
|
|
2015
|
||||||
Earnings (loss) attributable to Centene Corporation:
|
|
|
|
|
|
||||||
Earnings from continuing operations, net of tax
|
$
|
828
|
|
|
$
|
559
|
|
|
$
|
356
|
|
Discontinued operations, net of tax
|
—
|
|
|
3
|
|
|
(1
|
)
|
|||
Net earnings
|
$
|
828
|
|
|
$
|
562
|
|
|
$
|
355
|
|
|
|
|
|
|
|
||||||
Shares used in computing per share amounts:
|
|
|
|
|
|
|
|||||
Weighted average number of common shares outstanding
|
172,427
|
|
|
159,568
|
|
|
119,101
|
|
|||
Common stock equivalents (as determined by applying the treasury stock method)
|
4,275
|
|
|
4,407
|
|
|
3,965
|
|
|||
Weighted average number of common shares and potential dilutive common shares outstanding
|
176,702
|
|
|
163,975
|
|
|
123,066
|
|
|||
|
|
|
|
|
|
||||||
Net earnings (loss) per common share attributable to Centene Corporation:
|
|
|
|
|
|
||||||
Basic:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
4.80
|
|
|
$
|
3.50
|
|
|
$
|
2.99
|
|
Discontinued operations
|
—
|
|
|
0.02
|
|
|
(0.01
|
)
|
|||
Basic earnings per common share
|
$
|
4.80
|
|
|
$
|
3.52
|
|
|
$
|
2.98
|
|
|
|
|
|
|
|
||||||
Diluted:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
4.69
|
|
|
$
|
3.41
|
|
|
$
|
2.89
|
|
Discontinued operations
|
—
|
|
|
0.02
|
|
|
(0.01
|
)
|
|||
Diluted earnings per common share
|
$
|
4.69
|
|
|
$
|
3.43
|
|
|
$
|
2.88
|
|
|
Managed Care
|
|
Specialty
Services
|
|
Eliminations
|
|
Consolidated
Total
|
||||||||
Total revenues from external customers
|
$
|
45,798
|
|
|
$
|
2,584
|
|
|
$
|
—
|
|
|
$
|
48,382
|
|
Total revenues internal customers
|
44
|
|
|
9,471
|
|
|
(9,515
|
)
|
|
—
|
|
||||
Total revenues
|
$
|
45,842
|
|
|
$
|
12,055
|
|
|
(9,515
|
)
|
|
$
|
48,382
|
|
|
Earnings from operations
|
$
|
917
|
|
|
$
|
282
|
|
|
—
|
|
|
$
|
1,199
|
|
|
Total assets
|
$
|
19,959
|
|
|
$
|
1,896
|
|
|
—
|
|
|
$
|
21,855
|
|
|
Managed Care
|
|
Specialty
Services
|
|
Eliminations
|
|
Consolidated
Total
|
||||||||
Total revenues from external customers
|
$
|
38,182
|
|
|
$
|
2,425
|
|
|
$
|
—
|
|
|
$
|
40,607
|
|
Total revenues internal customers
|
200
|
|
|
5,952
|
|
|
(6,152
|
)
|
|
—
|
|
||||
Total revenues
|
$
|
38,382
|
|
|
$
|
8,377
|
|
|
$
|
(6,152
|
)
|
|
$
|
40,607
|
|
Earnings from operations
|
$
|
1,077
|
|
|
$
|
183
|
|
|
$
|
—
|
|
|
$
|
1,260
|
|
Total assets
|
$
|
18,423
|
|
|
$
|
1,774
|
|
|
$
|
—
|
|
|
$
|
20,197
|
|
|
Managed Care
|
|
Specialty
Services
|
|
Eliminations
|
|
Consolidated
Total
|
||||||||
Total revenues from external customers
|
$
|
20,865
|
|
|
$
|
1,895
|
|
|
$
|
—
|
|
|
$
|
22,760
|
|
Total revenues internal customers
|
101
|
|
|
4,862
|
|
|
(4,963
|
)
|
|
—
|
|
||||
Total revenues
|
$
|
20,966
|
|
|
$
|
6,757
|
|
|
$
|
(4,963
|
)
|
|
$
|
22,760
|
|
Earnings from operations
|
$
|
531
|
|
|
$
|
174
|
|
|
$
|
—
|
|
|
$
|
705
|
|
Total assets
|
$
|
6,327
|
|
|
$
|
1,012
|
|
|
$
|
—
|
|
|
$
|
7,339
|
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Expenses:
|
|
|
|
|
|
||||||
Selling, general and administrative expenses
|
$
|
7
|
|
|
$
|
10
|
|
|
$
|
9
|
|
Gain on contingent consideration
|
(1
|
)
|
|
(5
|
)
|
|
(44
|
)
|
|||
Other income (expense):
|
|
|
|
|
|
||||||
Investment and other income
|
2
|
|
|
2
|
|
|
(5
|
)
|
|||
Interest expense
|
(247
|
)
|
|
(201
|
)
|
|
(39
|
)
|
|||
Earnings (loss) before income taxes
|
(251
|
)
|
|
(204
|
)
|
|
(9
|
)
|
|||
Income tax benefit
|
(114
|
)
|
|
(76
|
)
|
|
(26
|
)
|
|||
Net earnings (loss) before equity in subsidiaries
|
(137
|
)
|
|
(128
|
)
|
|
17
|
|
|||
Equity in earnings from subsidiaries
|
945
|
|
|
686
|
|
|
341
|
|
|||
Net earnings
|
808
|
|
|
558
|
|
|
358
|
|
|||
(Earnings) loss attributable to noncontrolling interests
|
20
|
|
|
1
|
|
|
(2
|
)
|
|||
Net earnings attributable to Centene
|
$
|
828
|
|
|
$
|
559
|
|
|
$
|
356
|
|
|
|
|
|
|
|
||||||
Net earnings per share from continuing operations:
|
|
|
|
|
|
||||||
Basic earnings per common share
|
$
|
4.80
|
|
|
$
|
3.50
|
|
|
$
|
2.99
|
|
Diluted earnings per common share
|
$
|
4.69
|
|
|
$
|
3.41
|
|
|
$
|
2.89
|
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
||||||
Dividends from subsidiaries, return on investment
|
$
|
292
|
|
|
$
|
25
|
|
|
$
|
11
|
|
Other operating activities, net
|
(132
|
)
|
|
(71
|
)
|
|
(29
|
)
|
|||
Net cash provided by (used in) operating activities
|
160
|
|
|
(46
|
)
|
|
(18
|
)
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
||||||
Capital contributions to subsidiaries
|
(339
|
)
|
|
(691
|
)
|
|
(646
|
)
|
|||
Purchases of investments
|
(38
|
)
|
|
(112
|
)
|
|
(17
|
)
|
|||
Sales and maturities of investments
|
4
|
|
|
169
|
|
|
9
|
|
|||
Dividends from subsidiaries, return of investment
|
28
|
|
|
100
|
|
|
3
|
|
|||
Investments in acquisitions
|
(59
|
)
|
|
(2,248
|
)
|
|
(113
|
)
|
|||
Intercompany activities
|
322
|
|
|
(575
|
)
|
|
463
|
|
|||
Other investing activities, net
|
(1
|
)
|
|
—
|
|
|
7
|
|
|||
Net cash used in investing activities
|
(83
|
)
|
|
(3,357
|
)
|
|
(294
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
||||||
Proceeds from borrowings
|
1,400
|
|
|
8,934
|
|
|
1,925
|
|
|||
Payment of long-term debt
|
(1,350
|
)
|
|
(5,377
|
)
|
|
(1,575
|
)
|
|||
Common stock repurchases
|
(65
|
)
|
|
(63
|
)
|
|
(53
|
)
|
|||
Debt issuance costs
|
—
|
|
|
(76
|
)
|
|
(4
|
)
|
|||
Purchase of noncontrolling interest
|
(66
|
)
|
|
(14
|
)
|
|
—
|
|
|||
Other financing activities, net
|
5
|
|
|
—
|
|
|
20
|
|
|||
Net cash (used in) provided by financing activities
|
(76
|
)
|
|
3,404
|
|
|
313
|
|
|||
Net increase in cash and cash equivalents
|
1
|
|
|
1
|
|
|
1
|
|
|||
Cash and cash equivalents,
beginning of period
|
5
|
|
|
4
|
|
|
3
|
|
|||
Cash and cash equivalents,
end of period
|
$
|
6
|
|
|
$
|
5
|
|
|
$
|
4
|
|
(a)
|
Financial Statements and Schedules
|
1.
|
Financial Statements:
|
2.
|
Financial Statement Schedules:
|
3.
|
The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this filing.
|
|
|
|
|
|
|
INCORPORATED BY REFERENCE
1
|
|||||
EXHIBIT
NUMBER
|
|
DESCRIPTION
|
|
FILED
WITH THIS FORM
10-K
|
|
FORM
|
|
FILING DATE
WITH SEC
|
|
EXHIBIT
NUMBER
|
|
2.1
|
|
|
|
|
|
8-K
|
|
September 12, 2017
|
|
2.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
|
|
|
|
S-1
|
|
October 9, 2001
|
|
3.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1a
|
|
|
|
|
|
S-1/A
|
|
November 13, 2001
|
|
3.2a
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1b
|
|
|
|
|
|
10-Q
|
|
July 26, 2004
|
|
3.1b
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1c
|
|
|
|
|
|
S-3ASR
|
|
May 16, 2014
|
|
3.1c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1d
|
|
|
|
|
|
8-K
|
|
October 26, 2015
|
|
3.1
|
|
|
|
|
|
|
|
|
|
|
|
||
3.2
|
|
|
|
|
|
8-K
|
|
February 9, 2018
|
|
3.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.1
|
|
|
|
|
|
8-K
|
|
April 29, 2014
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
8-K
|
|
February 11, 2016
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.3
|
|
|
|
|
|
8-K
|
|
February 11, 2016
|
|
4.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.4
|
|
|
|
|
|
8-K
|
|
November 9, 2016
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
*
|
|
|
|
S-1
|
|
October 9, 2001
|
|
10.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
*
|
|
|
|
10-K
|
|
February 22, 2016
|
|
10.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.3
|
|
*
|
|
|
|
8-K
|
|
April 30, 2010
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4
|
|
*
|
|
|
|
8-K
|
|
April 27, 2017
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
10.5
|
|
*
|
|
|
|
10-Q
|
|
July 28, 2015
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.6
|
|
*
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7
|
|
*
|
|
|
|
8-K
|
|
April 26, 2007
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.8
|
|
*
|
|
|
|
10-K
|
|
February 22, 2011
|
|
10.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9
|
|
*
|
|
|
|
8-K
|
|
November 9, 2004
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9a
|
|
*
|
|
|
|
10-Q
|
|
October 28, 2008
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9b
|
|
*
|
|
|
|
10-Q
|
|
April 28, 2009
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9c
|
|
*
|
|
|
|
10-Q
|
|
October 23, 2012
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9d
|
|
*
|
|
|
|
8-K
|
|
May 16, 2013
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9e
'
|
|
*
|
|
|
|
8-K
|
|
December 14, 2016
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10
|
|
*
|
|
|
|
10-Q
|
|
October 28, 2008
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10a
|
|
*
|
|
|
|
10-Q
|
|
October 23, 2012
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10b
|
|
*
|
|
|
|
10-Q
|
|
April 28, 2015
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11
|
|
*
|
|
|
|
8-K
|
|
July 28, 2005
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12
|
|
*
|
|
|
|
10-Q
|
|
October 28, 2008
|
|
10.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13
|
|
*
|
|
|
|
10-K
|
|
February 23, 2009
|
|
10.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.14
|
|
*
|
|
|
|
10-Q
|
|
October 28, 2008
|
|
10.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.15
|
|
*
|
|
|
|
8-K
|
|
July 28, 2005
|
|
10.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.16
|
|
*
|
|
|
|
10-Q
|
|
October 25, 2005
|
|
10.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.17
|
|
*
|
|
|
|
10-K
|
|
February 22, 2016
|
|
10.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.18
|
|
*
|
|
|
|
10-K
|
|
February 21, 2017
|
|
10.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.19
|
|
*
|
|
|
|
10-K
|
|
February 22, 2016
|
|
10.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.20
|
|
*
|
|
|
|
10-K
|
|
February 22, 2016
|
|
10.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.21
|
|
*
|
|
|
|
10-K
|
|
February 21, 2017
|
|
10.23
|
|
|
|
|
|
|
|
|
|
|
|
|
CENTENE CORPORATION
|
||
|
|
|
By:
|
|
/s/ Michael F. Neidorff
|
|
|
Michael F. Neidorff
Chairman and Chief Executive Officer |
Signature
|
|
Title
|
|
|
|
/s/ Michael F. Neidorff
|
|
Chairman and Chief Executive Officer
(principal executive officer)
|
Michael F. Neidorff
|
|
|
|
|
|
/s/ Jeffrey A. Schwaneke
|
|
Executive Vice President and Chief Financial Officer (principal financial officer)
|
Jeffrey A. Schwaneke
|
|
|
|
|
|
/s/ Christopher R. Isaak
|
|
Senior Vice President, Corporate Controller and Chief Accounting Officer (principal accounting officer)
|
Christopher R. Isaak
|
|
|
|
|
|
/s/ Orlando Ayala
|
|
Director
|
Orlando Ayala
|
|
|
|
|
|
/s/ Robert K. Ditmore
|
|
Director
|
Robert K. Ditmore
|
|
|
|
|
|
/s/ Fred H. Eppinger
|
|
Director
|
Fred H. Eppinger
|
|
|
|
|
|
/s/ Richard A. Gephardt
|
|
Director
|
Richard A. Gephardt
|
|
|
|
|
|
/s/ John R. Roberts
|
|
Director
|
John R. Roberts
|
|
|
|
|
|
/s/ David L. Steward
|
|
Director
|
David L. Steward
|
|
|
|
|
|
/s/ Tommy G. Thompson
|
|
Director
|
Tommy G. Thompson
|
|
|
Less than 1 year
|
0%
|
1 year
|
10%
|
2 years
|
30%
|
3 years
|
60%
|
4 years
|
80%
|
5 years
|
100%
|
Table of Contents
|
||||||
|
|
|
|
|
Page
|
|
SECTION 1 DEFINITIONS
|
|
1
|
|
|||
1.1
Definitions
|
1
|
|
||||
1.2
Other Interpretive Provisions
|
31
|
|
||||
1.3
Limited Condition Transactions
|
|
33
|
|
|||
SECTION 2 COMMITMENTS OF THE LENDERS; BORROWING, CONVERSION AND LETTER OF CREDIT PROCEDURES
|
33
|
|
||||
2.1
Commitments
|
|
|
33
|
|
||
2.2
Revolving Loan Procedures
|
|
|
38
|
|
||
2.3
Letter of Credit Procedures
|
|
|
41
|
|
||
2.4
Swing Line Loans
|
|
|
45
|
|
||
2.5
Availability of Funds
|
|
|
47
|
|
||
2.6
Defaulting Lenders
|
|
47
|
|
|||
SECTION 3 EVIDENCING OF LOANS
|
|
48
|
|
|||
3.1
Notes
|
|
|
48
|
|
||
3.2
Recordkeeping
|
|
|
49
|
|
||
SECTION 4 INTEREST
|
49
|
|
||||
4.1
Interest Rates
|
|
|
49
|
|
||
4.2
Interest Payment Dates
|
|
|
50
|
|
||
4.3
Setting and Notice of Rates
|
|
|
50
|
|
||
4.4
Computation of Interest
|
|
|
50
|
|
||
SECTION 5 FEES
|
|
|
|
|
51
|
|
5.1
Facility Fee
|
|
|
51
|
|
||
5.2
Letter of Credit Fees
|
|
|
51
|
|
||
5.3
Administrative Agent’s Fees
|
|
|
52
|
|
||
SECTION 6 REDUCTION OR TERMINATION OF THE COMMITMENT; PREPAYMENTS
|
52
|
|
||||
6.1
Reduction or Termination of the Commitment
|
|
52
|
|
|||
6.2
Prepayments
|
|
|
52
|
|
||
6.3
Manner of Prepayments
|
|
|
53
|
|
||
6.4
Repayments
|
|
|
53
|
|
||
SECTION 7 MAKING AND PRORATION OF PAYMENTS; SETOFF; TAXES
|
54
|
|
||||
7.1
Making of Payments
|
|
|
54
|
|
||
7.2
Application of Certain Payments
|
|
54
|
|
7.3
Due Date Extension
|
|
54
|
|
|||
7.4
Setoff
|
|
|
54
|
|
||
7.5
Proration of Payments
|
|
|
55
|
|
||
7.6
Taxes
|
|
|
|
55
|
|
|
SECTION 8 INCREASED COSTS; SPECIAL PROVISIONS FOR EUROCURRENCY LOANS AND CDOR LOANS
|
58
|
|
||||
8.1
Increased Costs
|
|
|
58
|
|
||
8.2
Basis for Determining Interest Rate Inadequate or Unfair
|
60
|
|
||||
8.3
Changes in Law Rendering Eurocurrency Loans Unlawful
|
60
|
|
||||
8.4
Funding Losses
|
|
|
61
|
|
||
8.5
Right of Lenders to Fund through Other Offices
|
|
61
|
|
8.6
Discretion of Lenders as to Manner of Funding
|
61
|
|
|||||
8.7
Mitigation of Circumstances; Replacement of Lenders
|
62
|
|
|||||
8.8
Conclusiveness of Statements
|
|
|
62
|
|
|||
SECTION 9
REPRESENTATIONS AND WARRANTIES
|
63
|
|
|||||
9.1
Organization
|
|
|
63
|
|
|||
9.2
Authorization; No Conflict
|
|
|
63
|
|
|||
9.3
Validity and Binding Nature
|
|
|
63
|
|
|||
9.4
[Reserved]
|
|
|
|
63
|
|
||
9.5
No Material Adverse Change
|
|
|
63
|
|
|||
9.6
Litigation and Guarantee Obligations
|
|
|
63
|
|
|||
9.7
Ownership of Properties; Liens
|
|
|
64
|
|
|||
9.8
Equity Ownership; Subsidiaries
|
|
|
64
|
|
|||
9.9
Pension Plans
|
|
|
64
|
|
|||
9.10
Investment Company Act
|
|
|
65
|
|
|||
9.11
Regulation U, T, and X
|
|
|
65
|
|
|||
9.12
Taxes
|
|
|
65
|
|
|||
9.13
Solvency, etc.
|
|
|
65
|
|
|||
9.14
Environmental Matters
|
|
|
65
|
|
|||
9.15
Insurance
|
|
|
66
|
|
|||
9.16
Real Property
|
|
|
66
|
|
|||
9.17
Information
|
|
|
66
|
|
|||
9.18
Intellectual Property
|
|
|
67
|
|
|||
9.19
Labor Matters
|
|
|
67
|
|
|||
9.20
No Default
|
|
|
67
|
|
|||
9.21
Material Licenses
|
|
|
67
|
|
|||
9.22
Compliance with Material Laws
|
|
|
67
|
|
|||
9.23
Subordinated Debt
|
|
|
67
|
|
|||
9.24
Charitable Foundations
|
|
|
68
|
|
|||
9.25
PATRIOT Act; OFAC; Sanctions and Anti-Corruption and Anti-Money Laundering Laws
|
68
|
|
|||||
SECTION 10
AFFIRMATIVE COVENANTS
|
|
|
68
|
|
|||
10.1
Reports, Certificates and Other Information
|
|
|
69
|
|
|||
10.2
Books, Records and Inspections
|
|
71
|
|
||||
10.3
Maintenance of Property; Insurance
|
|
|
72
|
|
|||
10.4
Compliance with Laws; Payment of Taxes and Liabilities
|
72
|
|
10.5
Maintenance of Existence, Material Licenses, etc.
|
|
72
|
|
||||
10.6
Use of Proceeds
|
|
|
72
|
|
|||
10.7
Employee Benefit Plans
|
|
|
73
|
|
|||
10.8
Environmental Matters
|
|
|
73
|
|
|||
10.9
Credit Ratings
|
|
|
74
|
|
|||
10.10
Designation of Restricted and Unrestricted Subsidiaries
|
74
|
|
|||||
SECTION 11
NEGATIVE COVENANTS
|
|
|
74
|
|
|||
11.1
Debt
|
|
|
|
74
|
|
||
11.2
Liens
|
|
|
|
|
|
77
|
|
11.3
Restricted Payments
|
|
|
|
80
|
|
||
11.4
Mergers, Consolidations, Sales
|
|
81
|
|
||||
11.5
Modification of Organizational Documents
|
|
|
82
|
|
|||
11.6
Transactions with Affiliates
|
|
|
82
|
|
|||
11.7
Inconsistent Agreements
|
|
|
82
|
|
|||
11.8
Business Activities
|
|
|
84
|
|
|||
11.9
Investments
|
|
|
84
|
|
|||
11.10
Restriction of Amendments to Certain Documents
|
85
|
|
|||||
11.11
Fiscal Year
|
|
|
85
|
|
|||
11.12
Financial Covenants
|
|
|
|
86
|
|
||
11.13
Guaranties
|
|
|
|
86
|
|
||
11.14
Exceptions
|
|
|
86
|
|
|||
SECTION 12
CONDITIONS OF LENDING, ETC.
|
|
|
86
|
|
|||
12.1
[Reserved]
|
|
|
|
86
|
|
||
12.2
[Reserved]
|
|
|
|
86
|
|
||
12.3
Conditions
|
|
|
86
|
|
|||
SECTION 13
EVENTS OF DEFAULT AND THEIR EFFECT
|
87
|
|
|||||
13.1
Events of Default
|
|
|
|
87
|
|
||
13.2
Effect of Event of Default
|
|
|
89
|
|
|||
SECTION 14
AGENTS
|
|
|
|
89
|
|
||
14.1
Appointment of Agents
|
|
|
89
|
|
|||
14.2
Powers and Duties
|
|
|
90
|
|
|||
14.3
General Immunity
|
|
|
91
|
|
|||
14.4
Agents Entitled to Act as Lender
|
|
|
93
|
|
|||
14.5
Lenders’ Representations, Warranties and Acknowledgment
|
93
|
|
|||||
14.6
Right to Indemnity
|
|
93
|
|
||||
14.7
Successor Administrative Agent, Issuing Lender and Swing Line Lender
|
94
|
|
|||||
14.8
Withholding Taxes
|
|
95
|
|
||||
14.9
Administrative Agent May File Proofs of Claim
|
95
|
|
|||||
SECTION 15
GENERAL
|
|
|
96
|
|
|||
15.1
Waiver; Amendments
|
|
|
|
96
|
|
||
15.2
Notices
|
|
|
|
97
|
|
||
15.3
Computations
|
|
|
|
99
|
|
||
15.4
Costs, Expenses and Taxes
|
|
|
99
|
|
|||
15.5
Assignments; Participations
|
|
|
100
|
|
|||
15.6
Register
|
|
|
102
|
|
|||
15.7
Governing Law
|
|
|
103
|
|
15.8
Confidentiality
|
|
|
103
|
|
|||
15.9
Severability
|
|
|
104
|
|
|||
15.10
Nature of Remedies
|
|
|
104
|
|
|||
15.11
Entire Agreement
|
|
|
104
|
|
|||
15.12
[Reserved]
|
|
|
104
|
|
|||
15.13
Successors and Assigns
|
|
|
104
|
|
|||
15.14
Captions
|
|
|
104
|
|
|||
15.15
Customer Identification – USA Patriot Act Notice
|
|
105
|
|
||||
15.16
Indemnification by the Company
|
|
|
105
|
|
|||
15.17
Nonliability of Lenders
|
|
|
106
|
|
|||
15.18
Forum Selection and Consent to Jurisdiction
|
|
107
|
|
||||
15.19
Waiver of Jury Trial
|
|
|
107
|
|
|||
15.20
Statutory Notice-Oral Commitments
|
|
108
|
|
||||
15.21
Survival of Representation, Warranties and Agreements
|
108
|
|
|||||
15.22
Judgment Currency
|
108
|
|
|||||
15.23
Acknowledgement and Consent to Bail-In of EEA Financial Institutions
|
109
|
|
|||||
|
|
|
|
|
|
|
Level
|
Total Debt to EBITDA Ratio
|
LIBOR/
EURIBOR/CDOR Margin |
Base Rate Margin
|
Facility Fee Rate
|
L/C Fee Rate
|
I
|
Greater than or equal to 3.5:1
|
1.875%
|
0.875%
|
0.375%
|
1.875%
|
II
|
Greater than or equal to 3.0:1 but less than 3.5:1
|
1.750%
|
0.750%
|
0.250%
|
1.750%
|
III
|
Greater than or equal to 2.5:1 but less than 3.0:1
|
1.500%
|
0.500%
|
0.250%
|
1.500%
|
IV
|
Greater than or equal to 2.0:1 but less than 2.5:1
|
1.250%
|
0.250%
|
0.250%
|
1.250%
|
V
|
Greater than or equal to 1.5:1 but less than 2.0:1
|
1.000%
|
0.000%
|
0.250%
|
1.000%
|
VI
|
Less than 1.5:1
|
0.875%
|
0.000%
|
0.250%
|
0.875%
|
Issuing Lender
|
Letter of Credit Sublimit
|
Wells Fargo Bank, National Association
|
$75,000,000
|
Barclays Bank PLC
|
$75,000,000
|
Citibank, N.A.
|
$75,000,000
|
SunTrust Bank
|
$75,000,000
|
|
Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Earnings:
|
|
|
|
|
|
|
|
|
|
||||||||||
Pre-tax earnings from continuing operations
|
$
|
1,134
|
|
|
$
|
1,157
|
|
|
$
|
697
|
|
|
$
|
457
|
|
|
$
|
269
|
|
Addback:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed charges
|
311
|
|
|
262
|
|
|
65
|
|
|
50
|
|
|
37
|
|
|||||
Add (Subtract):
|
|
|
|
|
|
|
|
|
|
||||||||||
Noncontrolling interest
|
20
|
|
|
1
|
|
|
(2
|
)
|
|
7
|
|
|
(1
|
)
|
|||||
Total earnings
|
$
|
1,465
|
|
|
$
|
1,420
|
|
|
$
|
760
|
|
|
$
|
514
|
|
|
$
|
305
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed Charges:
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
$
|
255
|
|
|
$
|
217
|
|
|
$
|
43
|
|
|
$
|
35
|
|
|
$
|
27
|
|
Interest component of rental payments (1)
|
56
|
|
|
45
|
|
|
22
|
|
|
15
|
|
|
10
|
|
|||||
Total fixed charges
|
$
|
311
|
|
|
$
|
262
|
|
|
$
|
65
|
|
|
$
|
50
|
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Ratio of earnings to fixed charges
|
4.7
|
|
|
5.4
|
|
|
11.7
|
|
|
10.3
|
|
|
8.2
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
(1) Estimated at 33% of rental expense as a reasonable approximation of the interest factor.
|
List of Subsidiaries
|
|
Absolute Total Care, Inc., a South Carolina corporation
|
AcariaHealth Pharmacy #11, Inc., a Texas corporation
|
AcariaHealth Pharmacy #12, Inc., a New York corporation
|
AcariaHealth Pharmacy #13, Inc., a California corporation
|
AcariaHealth Pharmacy #14, Inc., a California corporation
|
AcariaHealth Pharmacy, Inc., a California corporation
|
AcariaHealth, Inc., a Delaware corporation
|
Access Health Solutions, LLC, a Florida LLC
|
Agate Resources, Inc., an Oregon corporation
|
Ambetter of Magnolia, Inc., a Mississippi corporation
|
Ambetter of Peach State Inc., a Georgia corporation
|
Arkansas Health & Wellness Health Plan, Inc., an Arkansas corporation
|
Arkansas Total Care, Inc., an Arkansas corporation
|
Arkansas Total Care Holding Company, LLC, a Delaware LLC
|
Bankers Reserve Life Insurance Company of Wisconsin, a Wisconsin corporation
|
Bridgeway Health Solutions of Arizona, Inc., an Arizona corporation
|
Buckeye Community Health Plan, Inc., an Ohio corporation
|
California Health and Wellness Plan, a California corporation
|
Cantina Laredo Clayton, LP, a Delaware limited partnership
|
Casenet S.R.O., a Czech Republic S.R.O.
|
Casenet, LLC, a Delaware LLC
|
CBHSP Arizona, Inc., an Arizona corporation
|
Celtic Group, Inc., a Delaware corporation
|
Celtic Insurance Company, an Illinois corporation
|
CeltiCare Health Plan of Massachusetts, Inc., a Massachusetts corporation
|
Cenpatico Behavioral Health of Arizona, LLC, an Arizona LLC
|
Cenpatico Behavioral Health, LLC, a California LLC
|
Cenpatico of Arizona Inc., an Arizona corporation
|
Centene Acquisition Corporation, a New York corporation
|
Centene Center, LLC, a Delaware LLC
|
Centene Center I, LLC, a Delaware LLC
|
Centene Center II, LLC, a Delaware LLC
|
Centene Center III, LLC, a Delaware LLC
|
Centene Company of New York, LLC, a New York LLC
|
Centene Company of Texas, LP, a Texas limited partnership
|
Centene Management Company, LLC, a Wisconsin LLC
|
Centene UK Limited, an English and Welsh private company
|
Centurion Correctional Healthcare of Massachusetts, LLC, a Massachusetts LLC
|
Centurion Group, Inc., a Delaware corporation
|
Centurion of Florida, LLC, a Florida LLC
|
Centurion of Minnesota, LLC, a Minnesota LLC
|
Centurion of Mississippi, LLC, a Mississippi LLC
|
Centurion of Tennessee, LLC, a Tennessee LLC
|
Centurion of Vermont, LLC, a Vermont LLC
|
Centurion, LLC, a Delaware LLC
|
Clayton Property Investment, LLC, a Delaware LLC
|
CMC Hanley, LLC, a Missouri LLC
|
CMC Real Estate Company, LLC, a Delaware LLC
|
Comfort Hospice of Missouri, LLC, a Michigan LLC
|
Comfort Hospice of Texas, LLC, a Michigan LLC
|
ComfortBrook Hospice, LLC, an Ohio LLC
|
Coordinated Care Corporation, an Indiana corporation
|
Coordinated Care of Washington, Inc., a Washington corporation
|
Country Style Health Care, LLC, a Texas LLC
|
Drummonds Medical Limited, an English and Welsh private company
|
Envolve Benefits Options, Inc., a Delaware corporation
|
Envolve Captive Insurance Company, Inc., a South Carolina corporation
|
Envolve Dental, Inc., a Delaware corporation
|
Envolve Dental of Florida, Inc., a Florida corporation
|
Envolve Dental of Texas, Inc., a Texas corporation
|
Envolve Dental IPA of New York, Inc., a New York corporation
|
Envolve Holdings, Inc., a Delaware corporation
|
Envolve, Inc., a Delaware corporation
|
Envolve - New York, Inc., a New York corporation
|
Envolve PeopleCare, Inc., a Delaware corporation
|
Envolve Pharmacy IPA, LLC, a New York LLC
|
Envolve Pharmacy Solutions, Inc., a Delaware corporation
|
Envolve Total Vision, Inc., a Delaware corporation
|
Envolve Vision Benefits, Inc., a Delaware corporation
|
Envolve Vision, Inc., a Delaware corporation
|
Envolve Vision of Florida, Inc., a Florida corporation
|
Envolve Vision of Texas, Inc., a Texas corporation
|
Family Nurse Care II, LLC, a Michigan LLC
|
Family Nurse Care of Ohio, LLC, a Michigan LLC
|
Family Nurse Care, LLC, a Michigan LLC
|
FH Assurance Company, a Cayman Islands corporation
|
FH Surgery Centers Inc., a California corporation
|
FH Surgery Limited, Inc., a California corporation
|
Foundation Care, LLC, a Missouri LLC
|
Foundation Health Facilities, Inc., a California corporation
|
GPT Acquisition, LLC, a Delaware LLC
|
Grace Hospice of Austin, LLC, a Michigan LLC
|
Grace Hospice of Grand Rapids, LLC, a Michigan LLC
|
Grace Hospice of Illinois, LLC, an Illinois LLC
|
Grace Hospice of Indiana, LLC, a Michigan LLC
|
Grace Hospice of San Antonio, LLC, a Michigan LLC
|
Grace Hospice of Virginia, LLC, a Michigan LLC
|
Grace Hospice of Wisconsin, LLC, a Michigan LLC
|
Granite State Health Plan, Inc., a New Hampshire corporation
|
Greater Sacramento Surgery Center LP, a California limited partnership
|
Hallmark Life Insurance Company, an Arizona corporation
|
Health Care Enterprises, LLC, a Delaware LLC
|
Health Net Access, Inc., an Arizona corporation
|
Health Net Community Solutions, Inc., a California corporation
|
Health Net Community Solutions of Arizona, Inc., an Arizona corporation
|
Health Net Federal Services, LLC, a Delaware LLC
|
Health Net Health Plan of Oregon, Inc., an Oregon corporation
|
Health Net, Inc., a Delaware corporation
|
Health Net Life Insurance Company, a California corporation
|
Health Net Life Reinsurance Company, a Cayman Islands corporation
|
Health Net of Arizona Administrative Services, Inc., an Arizona corporation
|
Health Net of Arizona, Inc., an Arizona corporation
|
Health Net of California, Inc., a California corporation
|
Health Net of California Real Estate Holdings, Inc., a California corporation
|
Health Net of Pennsylvania, LLC, a Pennsylvania LLC
|
Health Net of the Northeast, LLC, a Delaware LLC
|
Health Net One Payment Services, Inc., a Delaware corporation
|
Health Net Pharmaceutical Services, a California corporation
|
Health Net Preferred Providers, LLC, a Delaware LLC
|
Health Net Services Inc., a Delaware corporation
|
Health Net Veterans, LLC, a Delaware LLC
|
Health Plan Real Estate Holdings, Inc., a Missouri corporation
|
Healthy Louisiana Holdings, LLC, a Delaware LLC
|
Healthy Missouri Holdings, Inc., a Missouri corporation
|
Heritage Home Hospice, LLC, a Michigan LLC
|
Home State Health Plan, Inc., a Missouri corporation
|
HomeScripts.com, LLC, a Michigan LLC
|
Hospice DME Company, LLC, a Michigan LLC
|
HSI Advantage Health Holdings, Inc., a Delaware corporation
|
IAH of Florida, LLC, a Florida LLC
|
IlliniCare Health Plan, Inc., an Illinois corporation
|
Illinois Health Practice Alliance, LLC, a Delaware corporation
|
Integrated Mental Health Services, a Texas corporation
|
Integrated Pharmacy Systems, Inc., a Pennsylvania corporation
|
Kentucky Spirit Health Plan, Inc., a Kentucky corporation
|
LBB Industries, Inc., a Texas corporation
|
LifeShare Management Group, LLC, a New Hampshire LLC
|
LiveHealthier, Inc., a Delaware corporation
|
Louisiana Healthcare Connections, Inc., a Louisiana corporation
|
LSM Holdco, Inc., a Delaware corporation
|
Magnolia Health Plan, Inc., a Mississippi corporation
|
Managed Health Network, a California corporation
|
Managed Health Network, LLC, a Delaware LLC
|
Managed Health Services Insurance Corporation, a Wisconsin corporation
|
Massachusetts Partnership of Correctional Healthcare, LLC, a Massachusetts LLC
|
MHN Global Services, Inc., a Delaware corporation
|
MHN Government Services LLC, a Delaware LLC
|
MHN Government Services-Belgium, Inc., a Delaware corporation
|
MHN Government Services-Djibouti, Inc., a Delaware corporation
|
MHN Government Services-Germany, Inc., a Delaware corporation
|
MHN Government Services-Guam, Inc., a Delaware corporation
|
MHN Government Services-International, Inc., a Delaware corporation
|
MHN Government Services-Italy, Inc., a Delaware corporation
|
MHN Government Services-Japan, Inc., a Delaware corporation
|
MHN Government Services-Puerto Rico, Inc., a Delaware corporation
|
MHN Government Services-Turkey, Inc., a Delaware corporation
|
MHN Government Services-United Kingdom, Inc., a Delaware corporation
|
MHN Services, LLC, a California LLC
|
MHS Consulting International, Inc., a Delaware corporation
|
MHS Travel & Charter, Inc., a Wisconsin corporation
|
Michigan Complete Health, a Michigan corporation
|
National Pharmacy Services Inc., a Delaware corporation
|
Nebraska Total Care, Inc., a Nebraska corporation
|
Network Providers, LLC, a Delaware corporation
|
North Florida Health Services, Inc., a Florida corporation
|
Novasys Health, Inc., a Delaware corporation
|
Peach State Health Plan, Inc., a Georgia corporation
|
Pennsylvania Health Care Plan, Inc., a Pennsylvania corporation
|
Phoenix Home Health Care, LLC, a Delaware LLC
|
Pinnacle Home Care, LLC, a Texas LLC
|
Pinnacle Senior Care of Indiana, LLC, a Michigan LLC
|
Pinnacle Senior Care of Kalamazoo, LLC, a Michigan LLC
|
Pinnacle Senior Care of Missouri, LLC, a Michigan LLC
|
Pinnacle Senior Care of Wisconsin, LLC, a Wisconsin LLC
|
PrimeroSalud, S.L., a Spanish Sociedad Limitada
|
QualMed, Inc., a Delaware corporation
|
QualMed Plans for Health of Colorado, Inc., a Colorado corporation
|
QualMed Plans for Health of Pennsylvania, Inc., a Pennsylvania corporation
|
QualMed Plans for Health of Western Pennsylvania, Inc., a Pennsylvania corporation
|
R&C Healthcare, LLC, a Texas LLC
|
Rapid Respiratory Services, LLC, a Delaware LLC
|
RMED, LLC, a Florida LLC
|
RX Direct, Inc., a Texas corporation
|
Seniorcorps Peninsula, LLC, a Virginia LLC
|
SilverSummit Healthplan, Inc., a Nevada corporation
|
Specialty Therapeutic Care Holdings, LLC, a Delaware LLC
|
Specialty Therapeutic Care, GP, LLC, a Texas LLC
|
Specialty Therapeutic Care, LP, a Texas limited partnership
|
Sunflower State Health Plan, Inc., a Kansas corporation
|
Sunshine Health Holding, LLC, a Florida LLC
|
Sunshine State Health Plan, Inc., a Florida corporation
|
Superior HealthPlan, Inc., a Texas corporation
|
The Practice (Group) Limited, an English and Welsh private company
|
The Practice Health Division Limited , an English and Welsh private company
|
The Practice Properties Limited, an English and Welsh private company
|
The Practice Services Limited, an English and Welsh private company
|
Traditional Home Health Services, LLC, a Texas LLC
|
Trillium Community Health Plan, Inc., an Oregon corporation
|
U.S. Medical Management Holdings, Inc., a Delaware corporation
|
U.S. Medical Management, LLC, a Delaware LLC
|
USMM Accountable Care Network, LLC, a Delaware LLC
|
USMM Accountable Care Partners, LLC, a Delaware LLC
|
USMM Accountable Care Solutions, LLC, a Delaware LLC
|
1.
|
I have reviewed this
Annual Report on Form 10-K
of Centene Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Dated:
|
February 20, 2018
|
|
/s/ MICHAEL F. NEIDORFF
|
|
|
Chairman and Chief Executive Officer
(principal executive officer)
|
1.
|
I have reviewed this
Annual Report on Form 10-K
of Centene Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Dated:
|
February 20, 2018
|
|
/s/ JEFFREY A. SCHWANEKE
|
|
|
Executive Vice President and Chief Financial Officer
(principal financial officer)
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated:
|
February 20, 2018
|
|
/s/ MICHAEL F. NEIDORFF
|
|
|
Chairman and Chief Executive Officer
(principal executive officer)
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated:
|
February 20, 2018
|
|
/s/ JEFFREY A. SCHWANEKE
|
|
|
Executive Vice President and Chief Financial Officer
(principal financial officer)
|